DRUG NAME: Benzylpenicillin (Penicillin G)

INN: Benzylpenicillin
Common name in Indian practice: Penicillin G; Crystalline Penicillin (for the sodium/potassium salt)
USAN: Penicillin G (same active moiety — no discrepancy)

⚠️ CRITICAL — THREE CLINICALLY DISTINCT SALT FORMS:

Benzylpenicillin exists as three salt forms with fundamentally different pharmacokinetic profiles, routes of administration, indications, and safety considerations. These are NOT interchangeable. Confusing them is a documented cause of fatal medication errors.

Property	Benzylpenicillin Sodium/Potassium (“Crystalline Penicillin”)	Procaine Benzylpenicillin (“Procaine Penicillin G”)	Benzathine Benzylpenicillin (“Benzathine Penicillin G”)
Route	IV (preferred) or IM	IM ONLY	IM ONLY
Duration of action	Short-acting (~4–6 hours per dose)	Intermediate depot (~12–24 hours)	Long-acting depot (~3–4 weeks)
Peak levels	IV: immediate; IM: 15–30 min	IM: 1–4 hours (lower peak than crystalline)	IM: 24–48 hours (very low peak)
Achieves high serum levels?	✅ YES — high peak concentrations	Moderate	⛔ NO — only low sustained levels
Achieves CSF levels?	✅ YES (with inflamed meninges)	⛔ INADEQUATE	⛔ INADEQUATE
Can be given IV?	✅ YES	⛔ NEVER — FATAL RISK (Hoigné reaction; cardiopulmonary arrest)	⛔ NEVER — FATAL RISK (embolic cardiopulmonary arrest)
Typical use	Serious infections: meningitis, endocarditis, severe pneumonia, gas gangrene, neurosyphilis	Uncomplicated pneumonia, mild-moderate infections, congenital syphilis (when IV not feasible)	RF/RHD secondary prophylaxis, early syphilis (non-neurological), congenital syphilis prophylaxis

⛔ FATAL ERROR ALERT: Inadvertent IV administration of benzathine penicillin or procaine penicillin has caused cardiac arrest and death — documented cases exist from Indian hospitals. These depot formulations form a viscous suspension that, if injected IV, causes embolic phenomena (pulmonary microembolism, coronary occlusion). ALWAYS verify the salt form before administration. The vial label, not the prescription alone, must be checked at the bedside.

Therapeutic Class: Antibiotic

Subclass: Natural Penicillin (Beta-Lactam — Penicillinase-Susceptible)

ℹ️ Benzylpenicillin is the prototype and narrowest-spectrum penicillin. Its narrow spectrum is a clinical advantage — it targets gram-positive cocci (streptococci, susceptible staphylococci), Treponema pallidum, Neisseria meningitidis, Clostridium species, and selected gram-negative organisms with high selectivity and minimal disruption of normal flora compared to broader-spectrum agents.

Schedule (India):

Schedule H

All formulations (crystalline penicillin injection, procaine penicillin injection, benzathine penicillin injection) are Schedule H drugs. A valid prescription is required for dispensing.

Route(s):

Salt-form-dependent routes — strictly enforced:

Salt Form	Permitted Routes	Forbidden Routes
Benzylpenicillin sodium/potassium (Crystalline Penicillin)	IV (bolus or infusion — preferred); IM (acceptable)	—
Procaine benzylpenicillin (Procaine Penicillin)	IM only (deep intramuscular)	⛔ NEVER IV — risk of Hoigné reaction (pseudo-anaphylaxis), cardiac arrest
Benzathine benzylpenicillin (Benzathine Penicillin)	IM only (deep intramuscular into large muscle)	⛔ NEVER IV — risk of embolic cardiopulmonary arrest, death

ℹ️ No oral formulation exists for benzylpenicillin — the drug is acid-labile and is destroyed by gastric acid, making oral administration ineffective. The oral penicillin equivalent is phenoxymethylpenicillin (Penicillin V), which is acid-stable and used for mild infections and rheumatic fever prophylaxis (oral route). Phenoxymethylpenicillin is a separate drug with its own monograph.

Biosimilar Status:

Not a biologic — biosimilar classification not applicable. Benzylpenicillin is a small-molecule chemical drug (beta-lactam antibiotic) manufactured by fermentation of Penicillium chrysogenum followed by chemical processing.

Formulations Available in India:

1. Benzylpenicillin Sodium (Crystalline Penicillin G Sodium) — Powder for Injection:

Dosage Form	Strengths Available	Notes
Powder for injection (vial) — for reconstitution before IV or IM use	5 lakh units (500,000 IU; ~300 mg)	Commonly available. Suitable for paediatric dosing.
	10 lakh units (1,000,000 IU = 1 MU; ~600 mg)	Most commonly stocked strength in Indian hospitals.
	20 lakh units (2,000,000 IU = 2 MU; ~1,200 mg)	Available; used for adult high-dose regimens.
	50 lakh units (5,000,000 IU = 5 MU; ~3,000 mg)	Available at larger centres; reduces the number of vials needed for high-dose therapy (meningitis, endocarditis).

ℹ️ Unit convention in India: Indian practice commonly uses “lakh units” (1 lakh = 100,000). International practice uses “Mega Units” (MU; 1 MU = 1,000,000 IU = 10 lakh units). Both conventions appear on Indian prescription charts and in Indian textbooks. This monograph uses both for clarity.

ℹ️ Potassium content: Each 1 MU (10 lakh units) of benzylpenicillin sodium contains approximately 1.7 mEq of sodium. Benzylpenicillin potassium salt (less commonly available in India) contains approximately 1.7 mEq of potassium per 1 MU — ⚠️ this is clinically significant at high doses (e.g., 20–24 MU/day = 34–41 mEq potassium/day) and can cause hyperkalaemia, especially in patients with renal impairment. Monitor serum potassium if using the potassium salt at high doses. In India, the sodium salt is predominantly available and preferred.

2. Procaine Benzylpenicillin (Procaine Penicillin G) — Suspension for IM Injection:

Dosage Form	Strengths Available	Notes
Powder for suspension / pre-constituted suspension (vial) — for IM injection ONLY	4 lakh units (400,000 IU) per vial	Standard vial. Aqueous suspension — shake well before use.
	3 lakh units (300,000 IU) per mL in some formulations	Check specific product concentration.

ℹ️ Fortified Procaine Penicillin (FPP): A commonly available combination in India containing crystalline penicillin sodium + procaine penicillin in the same vial (e.g., crystalline penicillin 1 lakh units + procaine penicillin 3 lakh units = total 4 lakh units). This provides a rapid-onset component (crystalline) plus a depot component (procaine). Used for IM injection only. Widely available in India.

3. Benzathine Benzylpenicillin (Benzathine Penicillin G) — Suspension for IM Injection:

Dosage Form	Strengths Available	Notes
Powder for suspension (vial) — for IM injection ONLY	6 lakh units (600,000 IU) per vial	Paediatric dose vial.
	12 lakh units (1,200,000 IU = 1.2 MU) per vial	Standard adult dose vial for RF prophylaxis and early syphilis. The most commonly prescribed strength.
	24 lakh units (2,400,000 IU = 2.4 MU) per vial	Used for syphilis treatment (given as single dose or divided between two injection sites). Available but less commonly stocked than the 1.2 MU vial.

⚠️ CHRONIC SUPPLY SHORTAGE IN INDIA: Benzathine penicillin has experienced recurrent and severe supply shortages in India since approximately 2016–2017. Multiple manufacturers have intermittently ceased production, and global supply has been unreliable. This has critically impacted:

Rheumatic fever/RHD secondary prophylaxis — patients unable to receive 3-weekly or 4-weekly injections, leading to recurrent rheumatic fever episodes and RHD progression
Syphilis treatment — particularly congenital syphilis prevention (WHO elimination target)
National programmes — NVHCP (National Programme for Prevention and Control of RHD) and syphilis screening programmes

ℹ️ When benzathine penicillin is unavailable: See Clinical Pearls for alternative strategies recommended by Indian cardiologists and ICMR.

Fixed-dose combinations (FDCs):

FDC	Components	Notes
Fortified Procaine Penicillin (FPP)	Crystalline penicillin (benzylpenicillin sodium) + Procaine penicillin in same vial (various ratios — e.g., 1 lakh crystalline + 3 lakh procaine)	IM only. Widely available. Provides initial high levels (from crystalline component) plus sustained depot effect (from procaine component). Commonly used for community-acquired pneumonia, cellulitis, and soft tissue infections where IM is the only available route.

⛔ Banned formulations: No specific benzylpenicillin-containing FDC has been identified in recent CDSCO ban notifications for single-ingredient penicillin products. However, prescribers should verify individual FDC products against the latest CDSCO gazette notifications.

PHARMACOKINETICS

ℹ️ All three salt forms ultimately release the same active drug — benzylpenicillin. The pharmacokinetic differences between salt forms are due to differences in absorption rate from the IM injection site, not differences in metabolism or elimination. Once benzylpenicillin is absorbed into the systemic circulation, its distribution, metabolism, and excretion are identical regardless of the salt form.

Core PK parameters (for systemically absorbed benzylpenicillin):

Parameter	Value
Bioavailability (oral)	⛔ Negligible — benzylpenicillin is acid-labile; destroyed by gastric acid. Oral administration is NOT effective. No oral formulation exists.
Bioavailability (IM — crystalline)	Near-complete absorption from IM site; peak in 15–30 minutes.
Bioavailability (IM — procaine salt)	Slow, sustained absorption from IM depot; peak in 1–4 hours; therapeutic levels maintained for approximately 12–24 hours.
Bioavailability (IM — benzathine salt)	Very slow absorption from IM depot; peak at 24–48 hours (low peak concentration); low but sustained treponemicidal levels maintained for approximately 3–4 weeks.
Tmax	IV: immediate. IM crystalline: 15–30 min. IM procaine: 1–4 hours. IM benzathine: 24–48 hours.
Protein binding	Approximately 60% (moderate). Bound primarily to albumin.
Volume of distribution (Vd)	Approximately 0.3–0.4 L/kg (relatively low — distributes primarily in extracellular fluid). Penetrates well into most body tissues and fluids EXCEPT: eye (poor), CSF (poor with intact meninges; improved with inflamed meninges — see below), and prostatic fluid (poor).
CSF penetration	⚠️ Critical parameter for meningitis treatment. With intact meninges: ~1–2% of serum level (clinically inadequate). With inflamed meninges (meningitis): ~5–10% of serum level — sufficient when high IV doses are used (achieves therapeutic CSF concentrations of >0.06 mcg/mL against susceptible organisms). ⛔ Procaine penicillin and benzathine penicillin do NOT achieve adequate CSF levels even with inflamed meninges — the peak serum concentrations are too low. Only high-dose IV crystalline penicillin is suitable for meningitis and neurosyphilis.
Metabolism	Minimal hepatic metabolism (~10–20%). The beta-lactam ring undergoes some hydrolysis to penicilloic acid (inactive). Not dependent on CYP450 enzymes. Benzylpenicillin is NOT a significant CYP450 inhibitor, inducer, or substrate.
Drug transporter relevance	Benzylpenicillin is a substrate of OAT1 and OAT3 (organic anion transporters) in the renal tubule — these mediate active tubular secretion. This is the basis for the probenecid interaction (probenecid inhibits OAT-mediated tubular secretion → increases penicillin levels). Also a substrate of OAT at the choroid plexus (actively transported OUT of CSF → contributes to low CSF levels).
Active metabolites	None. Penicilloic acid (hydrolysis product) is inactive.
Half-life (t½)	30 minutes (very short) in adults with normal renal function. ⚠️ Prolonged in renal impairment: up to 4–10 hours in severe CKD / anuria. Prolonged in neonates: 1.5–10 hours (gestational age-dependent — premature neonates have the longest half-life due to immature renal tubular secretion).
Excretion	Primarily renal — approximately 60–90% excreted unchanged in the urine via: (a) glomerular filtration (~10%); (b) active tubular secretion (~50–80% — via OAT1/OAT3 transporters). Small amount (~10%) excreted via biliary route.
Dialysability	✅ YES — removed by haemodialysis. Supplemental dosing post-HD is recommended. Also partially removed by peritoneal dialysis (less efficiently). See RENAL ADJUSTMENT.
Food effect	Not applicable — no oral formulation.
Onset of action	IV: Bactericidal activity at the site of infection within minutes of achieving therapeutic serum levels. IM crystalline: 15–30 minutes. IM procaine: 1–4 hours. IM benzathine: 24–48 hours (low peak — suitable only for organisms highly sensitive to very low concentrations, e.g., T. pallidum, Group A Streptococcus).
Duration of action	IV/IM crystalline: 4–6 hours (necessitates frequent dosing — every 4–6 hours). IM procaine: 12–24 hours (allows once- or twice-daily IM dosing). IM benzathine: 3–4 weeks (allows once-monthly dosing for RF prophylaxis; single-dose treatment for early syphilis).

Pharmacodynamic note — Time-dependent killing:

ℹ️ Benzylpenicillin, like all beta-lactams, exhibits time-dependent bactericidal activity. The key pharmacodynamic parameter is %fT>MIC — the percentage of time that the free (unbound) drug concentration exceeds the minimum inhibitory concentration (MIC) of the target organism. Optimal bactericidal activity requires fT>MIC of approximately 50–60% (for penicillins; lower threshold than for cephalosporins).

Clinical implication: The short half-life (30 minutes) of crystalline penicillin means that frequent dosing (every 4 hours, or continuous IV infusion) is necessary to maintain serum levels above the MIC for the required proportion of the dosing interval. Extending the dosing interval (e.g., to every 8 or 12 hours) results in prolonged sub-MIC periods and reduced bactericidal efficacy, even if the peak concentration is high. This is why crystalline penicillin is dosed every 4 hours (6 times daily) for serious infections — not for pharmacokinetic reasons alone, but because of the time-dependent killing pharmacodynamics.

💡 Continuous IV infusion of crystalline penicillin maintains 100% fT>MIC and is used in some ICU protocols for severe infections. See Reconstitution section.

Non-linear PK: Not clinically significant at standard therapeutic doses. At very high doses (>24 MU/day), renal tubular secretion may approach saturation, resulting in slightly disproportionate increases in serum levels. This is rarely clinically relevant.

Population Pharmacokinetic Notes:

Population	PK Consideration
Elderly (≥60 years)	Reduced renal function (age-related GFR decline) → reduced penicillin clearance → prolonged half-life. Dose adjustment based on eGFR is recommended (see RENAL ADJUSTMENT). No specific dose reduction for age alone beyond renal adjustment.
Paediatric	Neonates (especially preterm): Markedly prolonged half-life (1.5–10 hours) due to immature renal tubular secretion (OAT1/3 transporters). Half-life decreases progressively with gestational and postnatal age. Term neonates (day 1): t½ ~3 hours; by day 14: ~1.5 hours. Preterm neonates (<32 weeks): t½ ~4–10 hours. Infants and children (>1 month): Clearance per kg is similar to or slightly higher than adults — standard weight-based dosing applies.
Pregnancy	Increased renal blood flow and GFR during pregnancy → increased penicillin clearance → lower serum levels at standard doses. Clinical significance is uncertain for most indications because penicillin has a wide therapeutic index. For syphilis treatment in pregnancy, standard benzathine penicillin doses are considered adequate based on extensive clinical experience (not PK studies).
Obesity	Low Vd (0.3–0.4 L/kg) — distributes primarily in extracellular water, not adipose tissue. In significantly obese patients, dosing based on ideal body weight (IBW) is generally appropriate. Actual body weight-based dosing may lead to unnecessarily high doses (though penicillin’s wide therapeutic index provides a large safety margin). For morbidly obese patients with serious infections, clinical judgement applies.
Renal impairment	⚠️ Major impact. 60–90% of benzylpenicillin is eliminated renally. In severe CKD, half-life increases from 30 minutes to 4–10 hours. Dose reduction or interval extension is required. Risk of neurotoxicity (seizures, myoclonus, encephalopathy) increases significantly with drug accumulation in renal failure. See RENAL ADJUSTMENT.
Critical illness / ICU	Altered Vd (third-spacing, oedema, ascites) may transiently increase Vd. Augmented renal clearance (ARC) in young septic patients may increase penicillin clearance → potentially subtherapeutic levels at standard doses. Continuous or extended infusions may be superior to intermittent bolus dosing in critically ill patients — maintains %fT>MIC more reliably.
Hepatic impairment	Minimal hepatic metabolism (~10–20%). No dose adjustment required for hepatic impairment alone.

Salt-form specific PK summary (comparative):

Parameter	Crystalline Penicillin (IV/IM)	Procaine Penicillin (IM)	Benzathine Penicillin (IM)
Peak serum concentration	High (IV: 20–50 mcg/mL after 2 MU dose; IM: 6–8 mcg/mL)	Moderate (1.5–4 mcg/mL after 600,000 IU)	Low (0.05–0.15 mcg/mL after 1.2 MU)
Time to peak	IV: immediate; IM: 15–30 min	1–4 hours	24–48 hours
Duration above 0.02 mcg/mL (treponemicidal concentration)	4–6 hours (per dose)	12–24 hours	21–28 days
Adequate for MIC of most streptococci (MIC ~0.01–0.06 mcg/mL)	✅ Yes	✅ Yes	✅ Yes (low but sufficient for highly susceptible organisms)
Adequate for meningitis (CSF levels needed)	✅ Yes (with high IV doses)	⛔ No (inadequate CSF penetration)	⛔ No
Adequate for endocarditis (sustained high bactericidal levels needed)	✅ Yes (with frequent IV dosing)	⛔ No (levels too intermittent and low)	⛔ No
Adequate for syphilis (treponemicidal levels needed)	✅ Yes (for neurosyphilis — high IV doses)	✅ Yes (for early syphilis — IM course)	✅ Yes (for early syphilis — single IM dose; for late latent — 3 weekly doses)

ADULT INDICATIONS + DOSING — FOR CLINICIAN USE ONLY

⛔ This section is a clinical reference for qualified prescribers only. Not for self-medication or patient self-dosing.

⚠️ OVERARCHING SAFETY PRINCIPLES FOR BENZYLPENICILLIN:

Always verify the SALT FORM before administration. Crystalline (sodium/potassium) penicillin, procaine penicillin, and benzathine penicillin are NOT interchangeable and have different routes, dosing, and indications. IV administration of procaine or benzathine penicillin is FATAL.
Always enquire about penicillin allergy before administration. True penicillin allergy (IgE-mediated anaphylaxis) is a contraindication to ALL penicillin formulations. Cross-reactivity with cephalosporins exists (~1–2% with modern cephalosporins).
Dose is expressed in units (IU), NOT milligrams, for all salt forms. The Indian convention of “lakh units” is used alongside international “Mega Units (MU)” throughout this monograph.
Time-dependent killing: Frequent dosing (every 4–6 hours) of crystalline penicillin is essential for efficacy — do NOT extend intervals for convenience unless renal dose adjustment is specifically indicated.

Primary Indications (Approved / Standard in India)

1. RHEUMATIC FEVER — SECONDARY PROPHYLAXIS / RHEUMATIC HEART DISEASE (RHD) PREVENTION

Salt form: BENZATHINE BENZYLPENICILLIN (IM only)

Clinical context: India carries the highest burden of rheumatic heart disease (RHD) globally — an estimated 25–30% of the world’s RHD cases. Secondary prophylaxis with benzathine penicillin is the single most effective intervention to prevent recurrent rheumatic fever episodes and progressive valvular damage. This indication is the cornerstone of the National Programme for Prevention and Control of RHD (NVHCP) in India.

Dosing — Adults and Adolescents:

Route	Dose	Frequency	Duration	Clinical Notes
IM (deep intramuscular — gluteal or anterolateral thigh)	12 lakh units (1.2 MU) as a single IM injection	Every 3 weeks (21 days) — PREFERRED in India. Alternative: every 4 weeks (28 days) — acceptable but slightly inferior in high-risk populations.	Duration depends on severity of disease — see below	⚠️ The 3-weekly interval is strongly recommended in Indian practice (API Textbook, ICMR guidelines, NVHCP protocol) because: (a) the Indian population may metabolise benzathine penicillin slightly faster; (b) tropical climate may increase injection site absorption; © 4-weekly regimens have been associated with breakthrough RF episodes in some Indian studies. The WHO recommends every 4 weeks as acceptable, but Indian expert consensus and ICMR favour every 3 weeks for high-risk patients.

Duration of prophylaxis — Indian guidelines (API Textbook / ICMR / NVHCP):

Clinical Scenario	Recommended Duration
RF WITHOUT carditis (no valvular involvement)	Minimum 5 years after the last episode of RF, OR until age 21 years — whichever is LONGER.
RF WITH carditis but NO residual valvular disease (carditis resolved without permanent valve damage)	Minimum 10 years after the last episode, OR until age 21 years — whichever is LONGER. Some guidelines recommend until age 25 years.
RF WITH residual valvular disease (RHD) — mild or moderate	Minimum 10 years after the last episode, OR until age 40 years — whichever is LONGER. API Textbook and many Indian cardiologists recommend lifelong prophylaxis.
Severe RHD (post-valve surgery / valve replacement)	⚠️ LIFELONG prophylaxis — recommended by most Indian cardiology centres (AIIMS, PGIMER, CMC Vellore protocols). Recurrent RF can damage even prosthetic valves and worsen residual native valve disease.

Mandatory Clinical Notes:

When to prefer this drug over alternatives: Benzathine penicillin IM is the ONLY recommended drug for RF secondary prophylaxis in India. It is superior to oral penicillin V because: (a) 100% bioavailability (no absorption variability); (b) guaranteed compliance (administered by healthcare worker); © long duration of action (3–4 weeks per injection); (d) oral penicillin V requires daily adherence for years — adherence rates in Indian studies are abysmally low (<30% in many settings). ℹ️ Oral penicillin V (250 mg BD) is an alternative ONLY when benzathine penicillin is unavailable or absolutely refused by the patient. Oral erythromycin (250 mg BD) is a second-line alternative for penicillin-allergic patients.
When NOT to use: ⛔ Confirmed IgE-mediated penicillin allergy (history of anaphylaxis, angioedema, urticaria within 1 hour of penicillin). In these patients, use oral erythromycin 250 mg BD (or azithromycin 250 mg daily — used in some Indian centres, though evidence is limited). ⚠️ Do NOT substitute with cephalosporins for RF prophylaxis — cross-reactivity risk (~1–2%) and no established evidence for RF prophylaxis with cephalosporins.
NLEM India status: ✅ Benzathine penicillin injection is listed in NLEM India 2022 — Section 6.2 (Antibacterials — Beta-lactam medicines). Both 6 lakh unit and 12 lakh unit vials are listed.
Time to response: Not applicable in the traditional sense — this is prophylaxis, not treatment. Effectiveness is measured by prevention of recurrent RF episodes. With regular 3-weekly prophylaxis, the recurrence rate of RF drops from ~20% per year (untreated) to <1% per year.
Criteria for treatment failure: Recurrent RF episode despite regular prophylaxis suggests: (a) non-adherence (missed injections); (b) 4-weekly interval may be insufficient — switch to 3-weekly; © inadequate injection technique (drug not deposited deep IM — superficial injection leads to faster absorption and shorter duration); (d) very rarely, penicillin-resistant GAS (not documented as clinically significant for RF prophylaxis to date).
Mandatory baseline investigations:
- MANDATORY: Echocardiography (to document baseline valvular status and severity of RHD — essential for determining duration of prophylaxis and surgical planning).
- RECOMMENDED: ASO titre, CRP/ESR (if acute RF episode is being evaluated); throat swab culture (to identify Group A Streptococcus carriage).
- MANDATORY before FIRST injection: Enquire specifically about penicillin allergy. Have adrenaline (epinephrine) injection 1:1000 and anaphylaxis management kit available at the injection site.
Specialist initiation: Initial diagnosis and classification of RF/RHD should be by a physician or cardiologist (Jones Criteria for diagnosis; echocardiography for classification). Ongoing monthly injections can be administered at PHC/CHC level by trained staff — this is the model promoted by NVHCP. RF prophylaxis should NOT be limited to tertiary centres.
Indian guideline source: ICMR Guidelines on RF/RHD Prevention (2008 — still referenced; updated practice incorporates 3-weekly regimen); API Textbook of Medicine (current edition) — Chapter on Rheumatic Fever and RHD; NVHCP (National Programme for Prevention and Control of RHD) operational guidelines; Indian Heart Journal — position statements on RF prophylaxis.
Key disease-specific safety warning: ⚠️ Anaphylaxis risk: Benzathine penicillin injections carry a small but non-zero risk of anaphylaxis (~0.01–0.05% per injection). Given that patients receive injections every 3–4 weeks for years or decades, the cumulative exposure is significant. Every injection centre MUST have: (a) adrenaline (epinephrine) 1:1000 ampoule and syringe ready; (b) trained staff who can recognise and manage anaphylaxis; © at least 30 minutes of post-injection observation before the patient leaves. ⚠️ Hoigné reaction (pseudo-anaphylaxis): A non-allergic reaction specific to procaine-containing and benzathine penicillin injections — presents with acute fear of death, visual/auditory disturbances, agitation, bizarre behaviour, tachycardia, and sometimes seizures. It is NOT IgE-mediated, is NOT fatal (unlike true anaphylaxis), and resolves spontaneously within 15–30 minutes with supportive care (reassurance, benzodiazepine for agitation). It is thought to be caused by microemboli of the depot suspension reaching the CNS. Differentiation from true anaphylaxis is critical — Hoigné reaction does NOT have: urticaria, angioedema, bronchospasm, or hypotension. Do NOT administer adrenaline for Hoigné reaction unless anaphylaxis features are present.
Common dose adjustment scenarios:
- Renal impairment: Not applicable — benzathine penicillin IM achieves very low serum levels that are well below the threshold for penicillin neurotoxicity. No dose adjustment needed for renal impairment in the prophylaxis context.
- Hepatic impairment: No adjustment needed.
- Body weight ≥27 kg (children transitioning to adult dose): Use the full 12 lakh unit (1.2 MU) dose. Children <27 kg: use 6 lakh units (600,000 IU). See Paediatric Dosing.
- Pregnancy: Benzathine penicillin is safe in pregnancy (Category B). RF prophylaxis must NOT be interrupted during pregnancy.

2. SYPHILIS — EARLY (PRIMARY, SECONDARY, EARLY LATENT <1 YEAR)

Salt form: BENZATHINE BENZYLPENICILLIN (IM only)

Clinical context: Benzylpenicillin remains the ONLY recommended treatment for all stages of syphilis. Treponema pallidum has never developed resistance to penicillin despite >75 years of use — making it one of the most reliably effective antimicrobial treatments in medicine. India has a significant syphilis burden, with antenatal screening programmes identifying cases for prevention of congenital syphilis.

Dosing — Adults:

Stage	Route	Dose	Frequency	Total Course	Notes
Primary syphilis (chancre)	IM	24 lakh units (2.4 MU) as a single IM injection	SINGLE DOSE	One injection only	Divide between two injection sites (12 lakh units per gluteal muscle) for the 2.4 MU dose because of the large volume of suspension.
Secondary syphilis (rash, condylomata, constitutional symptoms)	IM	24 lakh units (2.4 MU) as a single IM injection	SINGLE DOSE	One injection only	Same as primary.
Early latent syphilis (<1 year duration)	IM	24 lakh units (2.4 MU) as a single IM injection	SINGLE DOSE	One injection only	Same as primary.

ℹ️ If 2.4 MU vials are unavailable (common due to supply issues in India): Use two vials of 12 lakh units (1.2 MU each) = total 2.4 MU, given as two separate IM injections at different sites.

Mandatory Clinical Notes:

When to prefer over alternatives: Benzathine penicillin is the ONLY recommended first-line treatment for early syphilis (NACO, WHO, CDC guidelines). There is NO equivalent alternative for efficacy and simplicity. For penicillin-allergic non-pregnant patients: doxycycline 100 mg BD × 14 days is the alternative. For penicillin-allergic pregnant women: penicillin desensitisation is recommended (not avoidance) — no alternative to penicillin has proven efficacy for preventing congenital syphilis.
When NOT to use: ⛔ Confirmed penicillin allergy (IgE-mediated). ⛔ Do NOT use benzathine penicillin for neurosyphilis or ocular syphilis — inadequate CSF and ocular penetration (see Indication 4 below).
NLEM India status: ✅ NLEM-listed (benzathine penicillin injection).
Time to response: Chancre healing: 1–3 weeks. Rash resolution: 3–6 weeks. Serological response (RPR/VDRL titre decline): ≥4-fold decline within 6–12 months (considered adequate response). Slower decline does not necessarily indicate treatment failure — it may indicate late treatment or re-infection.
Treatment failure criteria: Failure of RPR/VDRL titre to decline ≥4-fold within 6–12 months, OR a ≥4-fold rise in titre after initial decline. Consider: (a) re-infection (most common cause of apparent “failure”); (b) undiagnosed neurosyphilis (lumbar puncture indicated); © HIV co-infection (may have delayed serological response). Re-treat with benzathine penicillin 2.4 MU IM weekly × 3 doses.
Baseline investigations: MANDATORY: Confirm diagnosis (darkfield microscopy if chancre available; RPR/VDRL + confirmatory treponemal test [TPHA/FTA-ABS]). MANDATORY: HIV testing (all syphilis patients must be tested for HIV — NACO guidelines). RECOMMENDED: CSF examination if neurological symptoms, ocular symptoms, treatment failure, or HIV with CD4 <350.
Specialist initiation: Not required for early syphilis. Primary care/PHC prescribing is appropriate. NACO/NACP-designated STI clinics handle diagnosis and treatment.
Indian source: NACO (National AIDS Control Organisation) STI Treatment Guidelines (current edition); WHO Guidelines on Syphilis Treatment (2016); API Textbook of Medicine.
Safety warning: ⚠️ Jarisch-Herxheimer reaction (JHR): Occurs in 10–35% of patients treated for early syphilis (especially secondary syphilis). Onset: 2–8 hours after first penicillin injection. Presents as: acute fever (38–40°C), rigors, headache, myalgia, tachycardia, flushing, worsening of rash, and hypotension (rarely). Caused by release of treponemal endotoxin-like lipoproteins from dying organisms — NOT an allergic reaction. Usually self-limiting (12–24 hours). Management: Paracetamol, hydration, reassurance. Does NOT require discontinuation of penicillin treatment. ⚠️ In pregnant women, JHR can cause uterine contractions and fetal distress — treat syphilis in pregnancy with obstetric monitoring available.
Dose adjustment: No renal or hepatic adjustment needed for single-dose benzathine penicillin.

3. SYPHILIS — LATE LATENT (>1 YEAR OR UNKNOWN DURATION), TERTIARY (NON-NEUROLOGICAL)

Salt form: BENZATHINE BENZYLPENICILLIN (IM only)

Dosing — Adults:

Stage	Route	Dose	Frequency	Total Course	Notes
Late latent syphilis (>1 year or unknown duration)	IM	24 lakh units (2.4 MU) per injection	Once weekly × 3 weeks (total 3 injections)	Total: 72 lakh units (7.2 MU) over 3 weeks	⚠️ If a weekly dose is missed by >14 days, the course should be restarted from the beginning. If missed by <14 days, give the dose and continue the schedule.
Tertiary syphilis (cardiovascular, gummatous — non-neurological)	IM	Same as late latent	Same	Same	Before treating cardiovascular syphilis, rule out neurosyphilis (LP recommended). Aortitis, aortic regurgitation, and coronary ostial stenosis are manifestations — these require concurrent cardiology management alongside antibiotic therapy.

Key clinical notes:

Always rule out neurosyphilis (by LP) before treating late syphilis with benzathine penicillin — if neurosyphilis is present, benzathine penicillin is INADEQUATE (see Indication 4).
Serological follow-up: RPR/VDRL at 6, 12, and 24 months post-treatment. A ≥4-fold decline indicates adequate response (may take longer than for early syphilis).

4. NEUROSYPHILIS AND OCULAR SYPHILIS

Salt form: CRYSTALLINE BENZYLPENICILLIN SODIUM (IV only)

⚠️ This is the ONLY form of penicillin that achieves adequate CSF levels for neurosyphilis.

Dosing — Adults:

Route	Dose	Frequency	Duration	Notes
IV	18–24 MU per day (180–240 lakh units/day), administered as 3–4 MU (30–40 lakh units) IV every 4 hours (6 divided doses)	Every 4 hours (continuous clock — including overnight doses)	10–14 days	⚠️ Requires inpatient treatment with IV access for the entire duration. Continuous IV infusion of 18–24 MU/day is an acceptable alternative to intermittent bolus dosing.

Alternative regimen (when IV not feasible): Procaine penicillin 2.4 MU (24 lakh units) IM once daily + probenecid 500 mg oral QID × 10–14 days. The probenecid blocks renal tubular secretion, raising serum and CSF penicillin levels. ⚠️ This regimen is inferior to IV crystalline penicillin and should be used ONLY when IV therapy is genuinely impossible. Probenecid adherence must be strictly maintained — missed probenecid doses render the regimen subtherapeutic.

Mandatory Clinical Notes:

When to prefer: IV crystalline penicillin is the only recommended treatment for neurosyphilis and ocular syphilis (NACO, WHO, CDC). ⛔ Benzathine penicillin does NOT achieve adequate CSF or ocular levels — it must NEVER be used for neurosyphilis.
NLEM status: Crystalline penicillin is NLEM-listed.
Time to response: Clinical improvement (resolution of meningitis symptoms, stabilisation of cranial neuropathies) within days to weeks. CSF normalisation (cell count, protein): 6–12 months. Repeat LP at 6 months post-treatment to confirm CSF improvement.
Baseline investigations: MANDATORY: Lumbar puncture (CSF cell count, protein, glucose, CSF-VDRL); HIV testing; RPR/VDRL titre. RECOMMENDED: MRI brain if focal neurological deficits.
Treatment failure: CSF-VDRL remains positive, or CSF pleocytosis persists at 6 months — consider retreatment with the same IV regimen. If HIV-positive, response may be slower.
Indian source: NACO STI Treatment Guidelines; API Textbook of Medicine.
Safety warning: ⚠️ JHR can cause acute worsening of neurological symptoms (seizures, cranial nerve palsies, stroke-like episodes) — monitor in hospital. ⚠️ At high IV doses (18–24 MU/day), monitor for penicillin neurotoxicity (see Serious Adverse Effects) — especially in patients with concurrent renal impairment.

5. BACTERIAL MENINGITIS — MENINGOCOCCAL (Neisseria meningitidis)

Salt form: CRYSTALLINE BENZYLPENICILLIN SODIUM (IV only)

Clinical context: Benzylpenicillin remains the drug of choice for confirmed or strongly suspected meningococcal meningitis (once susceptibility is established or in settings where meningococcal penicillin resistance is rare). In India, meningococcal disease occurs in epidemic outbreaks (particularly meningitis belt regions and crowded settings — military, pilgrimages, slums). Empirical treatment of bacterial meningitis in India typically starts with ceftriaxone (before susceptibility results), but benzylpenicillin is the definitive treatment once meningococcal aetiology is confirmed.

Dosing — Adults:

Route	Dose	Frequency	Duration	Notes
IV	24 lakh units (2.4 MU) IV every 4 hours (= total 144 lakh units or 14.4 MU per day in 6 divided doses)	Every 4 hours (continuous clock)	7 days (meningococcal meningitis — shorter course than pneumococcal)	Some protocols use 4 MU (40 lakh units) every 4 hours (= 24 MU/day) for the initial 48 hours, then reduce to 2.4 MU every 4 hours. Continuous IV infusion is an alternative.

ℹ️ Pre-hospital benzylpenicillin: In the UK, pre-hospital IM/IV benzylpenicillin is standard for suspected meningococcal disease before transfer to hospital. This practice is less standardised in India but is appropriate in remote settings where hospital transfer will be delayed — give crystalline penicillin 2.4 MU (24 lakh units) IV or IM stat before transfer.

Mandatory Clinical Notes:

When to prefer over alternatives: Benzylpenicillin is the narrowest-spectrum effective agent for meningococcal meningitis and is preferred over ceftriaxone once meningococcal aetiology is confirmed — it minimises disruption of normal flora and collateral resistance pressure. However, ceftriaxone 2 g IV BD (or cefotaxime 2 g IV every 4–6 hours) is the standard empirical therapy for suspected bacterial meningitis in India (covers meningococcal, pneumococcal, and H. influenzae). Switch to benzylpenicillin once culture/sensitivity confirms meningococcus with penicillin MIC ≤0.06 mcg/mL (susceptible).
When NOT to use: ⚠️ Empirically — do NOT use benzylpenicillin as empirical meningitis therapy without susceptibility data. In India, pneumococcal meningitis (which may have intermediate or full penicillin resistance) is common, and benzylpenicillin alone would be inadequate. Empirical therapy must be ceftriaxone ± vancomycin (for suspected penicillin-resistant pneumococcus) ± ampicillin (for Listeria in elderly/immunocompromised).
NLEM status: ✅ NLEM-listed.
Time to response: Clinical improvement (fever defervescence, improving consciousness) expected within 48–72 hours. If no improvement by 48 hours, reassess: repeat LP, broaden coverage, consider alternative diagnoses (TB meningitis is a common differential in India).
Baseline investigations: MANDATORY: LP before antibiotics if possible (CSF Gram stain, culture, protein, glucose, cell count); blood cultures × 2 sets; CBC, CRP, electrolytes, renal function. Do NOT delay antibiotics for LP if the patient is critically ill — give antibiotics first, then LP as soon as feasible.
Specialist initiation: Initial management should be by a physician, intensivist, or paediatrician experienced in meningitis management. PHC-level initiation of empirical antibiotics (ceftriaxone) before referral is appropriate and recommended.
Indian source: ICMR guidelines on bacterial meningitis management; API Textbook of Medicine; NCDC meningococcal disease outbreak response protocol.
Safety warning: ⚠️ Monitor serum electrolytes (sodium content of crystalline penicillin — hypernatraemia risk at high doses). ⚠️ Monitor for seizures (both from meningitis and from potential penicillin neurotoxicity at high doses in patients with concurrent renal impairment).
Dose adjustment in renal impairment: Reduce dose if eGFR <30 (see RENAL ADJUSTMENT). ⚠️ In meningitis, dose reduction must balance the risk of neurotoxicity (from accumulation) against the risk of therapeutic failure (from subtherapeutic CSF levels). Consult infectious disease specialist.

6. INFECTIVE ENDOCARDITIS — PENICILLIN-SUSCEPTIBLE STREPTOCOCCI (Viridans Group Streptococci, S. gallolyticus)

Salt form: CRYSTALLINE BENZYLPENICILLIN SODIUM (IV only)

Clinical context: Benzylpenicillin is the cornerstone of treatment for infective endocarditis (IE) caused by penicillin-susceptible streptococci (MIC ≤0.12 mcg/mL). In India, rheumatic valvular disease is the most common predisposing factor for IE, and viridans group streptococci remain the most common cause of subacute native valve IE.

Dosing — Adults:

Susceptibility	Route	Dose	Frequency	Duration	Combination	Notes
Penicillin MIC ≤0.12 mcg/mL (fully susceptible)	IV	12–18 MU/day (120–180 lakh units/day) in 6 divided doses (= 2–3 MU every 4 hours)	Every 4 hours (continuous clock)	4 weeks (native valve); 6 weeks (prosthetic valve)	± Gentamicin 1 mg/kg IV every 8 hours × first 2 weeks (synergistic regimen — allows shortened course to 2 weeks total in selected cases with native valve IE and no complications)	Continuous IV infusion (12–18 MU/day) is an acceptable alternative.
Penicillin MIC 0.12–0.5 mcg/mL (relatively resistant)	IV	24 MU/day (240 lakh units/day) in 6 divided doses (= 4 MU every 4 hours)	Every 4 hours	4 weeks (native valve); 6 weeks (prosthetic valve)	+ Gentamicin 1 mg/kg IV every 8 hours × first 2 weeks	Higher penicillin dose needed.

Mandatory Clinical Notes:

When to prefer: Benzylpenicillin is the gold standard for penicillin-susceptible streptococcal IE — highest published cure rates (~98% microbiological cure for fully susceptible strains). Preferred over ceftriaxone when patient is hospitalised with reliable IV access. Ceftriaxone 2 g IV OD × 4 weeks is an alternative for outpatient parenteral antibiotic therapy (OPAT) — possible in select stable patients.
When NOT to use: ⛔ Penicillin MIC >0.5 mcg/mL — treat as enterococcal endocarditis protocol (ampicillin + gentamicin or ampicillin + ceftriaxone). ⛔ Staphylococcal IE — requires anti-staphylococcal agents (cloxacillin, vancomycin). ⛔ Enterococcus IE — requires ampicillin (not penicillin G) + gentamicin/ceftriaxone synergy.
NLEM status: ✅ NLEM-listed.
Time to response: Blood cultures should become negative within 48–72 hours of initiating appropriate therapy. Persistent positive cultures after 7 days suggest: perivalvular abscess, wrong antibiotic, wrong diagnosis, or metastatic infection.
Baseline investigations: MANDATORY: ≥3 sets blood cultures (before antibiotics); echocardiography (TTE first; TOE if TTE inconclusive or prosthetic valve); CBC, CRP, ESR, renal function, urinalysis (microscopic haematuria). RECOMMENDED: Duke Criteria assessment for definitive diagnosis.
Specialist initiation: Mandatory — IE management requires a cardiologist and infectious disease specialist (or experienced physician). Surgery consultation for all patients.
Indian source: API Textbook of Medicine — IE chapter; AHA/ESC IE Guidelines (adapted for Indian practice); AIIMS IE protocols.
Safety warning: ⚠️ Monitor renal function and gentamicin trough levels (target <1 mcg/mL) to prevent aminoglycoside nephrotoxicity and ototoxicity. ⚠️ Monitor for penicillin neurotoxicity (seizures) at high doses — especially if renal function declines during the prolonged treatment course.
Dose adjustment: Reduce crystalline penicillin dose if eGFR <30 mL/min (see RENAL ADJUSTMENT). Adjust gentamicin per renal function and TDM.

7. GAS GANGRENE (CLOSTRIDIAL MYONECROSIS) AND SEVERE CLOSTRIDIAL INFECTIONS

Salt form: CRYSTALLINE BENZYLPENICILLIN SODIUM (IV only)

Dosing — Adults:

Route	Dose	Frequency	Duration	Combination	Notes
IV	4 MU (40 lakh units) IV every 4 hours (= 24 MU/day)	Every 4 hours	Until clinical resolution; minimum 10–14 days	+ Clindamycin 600–900 mg IV every 8 hours (suppresses toxin production — acts synergistically with penicillin)	⚠️ Gas gangrene is a surgical emergency — antibiotic therapy is adjunctive to urgent surgical debridement. Antibiotics WITHOUT surgery are inadequate. Penicillin kills Clostridium perfringens rapidly; clindamycin inhibits toxin synthesis at the ribosomal level.

Key clinical notes:

This is a SURGICAL EMERGENCY. Refer to surgery immediately. Antibiotics support, but do not replace, debridement.
Clostridium perfringens remains universally susceptible to penicillin. No resistance has been documented.
Hyperbaric oxygen therapy (HBO) is an adjunct at select Indian tertiary centres — benefit is debated but may be considered if available.
Indian source: API Textbook of Medicine; surgical textbooks (SRB’s Manual of Surgery, Bailey & Love).

8. COMMUNITY-ACQUIRED PNEUMONIA — PNEUMOCOCCAL (SUSCEPTIBLE)

Salt forms: CRYSTALLINE PENICILLIN (IV — for severe/hospitalised) or PROCAINE PENICILLIN (IM — for moderate/outpatient)

Dosing — Adults:

Severity	Salt Form	Route	Dose	Frequency	Duration	Notes
Severe / Hospitalised CAP (CURB-65 ≥2 or requiring ICU)	Crystalline penicillin	IV	2 MU (20 lakh units) IV every 4–6 hours (= 8–12 MU/day)	Every 4–6 hours	7–10 days (switch to oral amoxicillin when improving — “IV-to-oral switch”)	Empirical therapy for hospitalised CAP in India is usually ceftriaxone + azithromycin (covers atypicals and resistant pneumococcus). Switch to IV crystalline penicillin if culture confirms penicillin-susceptible S. pneumoniae (MIC ≤2 mcg/mL for non-meningeal pneumococcal pneumonia — note: higher MIC breakpoint than for meningitis).
Moderate / Non-severe (CURB-65 0–1, outpatient or step-down)	Procaine penicillin	IM	6–12 lakh units (600,000–1,200,000 IU) IM once daily	Once daily	7 days	⚠️ Procaine penicillin IM is IM ONLY. Useful in PHC/CHC settings where IV therapy is not available but the patient needs parenteral antibiotics. Provides sustained levels for 12–24 hours with once-daily dosing. Fortified Procaine Penicillin (FPP) — 4 lakh units IM OD or BD — is commonly used in Indian primary care.

Key clinical notes:

⚠️ Pneumococcal penicillin resistance in India: The rate of penicillin-non-susceptible S. pneumoniae (PNSP) in India is approximately 5–15% (varies by region and study). However, for non-meningeal pneumococcal infections (pneumonia, bacteraemia), the revised CLSI breakpoints (2008) set the susceptible breakpoint at MIC ≤2 mcg/mL (much higher than for meningitis — ≤0.06). Most “intermediate resistance” pneumococci by old breakpoints are actually susceptible by current non-meningeal breakpoints. High-dose IV penicillin (2 MU every 4 hours) achieves serum levels well above MIC 2 mcg/mL.
Empirical therapy for CAP in India (API Textbook, ICMR guidelines) is amoxicillin (oral, for mild CAP) or ceftriaxone + azithromycin (IV, for moderate-severe CAP). Benzylpenicillin is used as definitive therapy once culture confirms susceptible pneumococcus — narrower spectrum, lower resistance pressure.

9. DIPHTHERIA — ADJUNCTIVE TO ANTITOXIN

Salt form: CRYSTALLINE PENICILLIN (IV) or PROCAINE PENICILLIN (IM)

Dosing — Adults:

Route	Dose	Frequency	Duration	Notes
IV (preferred for severe/pharyngeal diphtheria)	2 MU (20 lakh units) IV every 6 hours (= 8 MU/day)	Every 6 hours	14 days	⚠️ Antitoxin (DAT) is the PRIMARY treatment — antibiotics are adjunctive (eradicate the organism and prevent transmission but do NOT neutralise circulating toxin). Administer DAT first, then antibiotics.
IM (procaine penicillin — if IV not available)	6 lakh units (600,000 IU) IM once daily	Once daily	14 days	Alternative route for settings without IV access.

Alternative antibiotic: Erythromycin 500 mg QID × 14 days (for penicillin-allergic patients). Azithromycin may be used but is not standard.

Indian source: NCDC Diphtheria Treatment Module; ICMR guidelines; IAP recommendations.

10. TETANUS — ADJUNCTIVE ANTIBIOTIC THERAPY

Salt form: CRYSTALLINE PENICILLIN (IV) or PROCAINE PENICILLIN (IM)

Dosing — Adults:

Route	Dose	Frequency	Duration	Notes
IV (preferred)	2 MU (20 lakh units) IV every 6 hours (= 8 MU/day)	Every 6 hours	10–14 days	⚠️ Primary treatment is wound debridement + tetanus immunoglobulin (TIG) + supportive care (ICU). Antibiotics eradicate C. tetani from the wound. Metronidazole 500 mg IV every 8 hours is now preferred over penicillin G for tetanus because metronidazole does NOT have the GABA-antagonist activity that penicillin has at high CNS concentrations (theoretical concern: penicillin’s central effects may worsen tetanus spasms). API Textbook and current Indian practice recommend metronidazole as first-line antibiotic for tetanus; penicillin G is an alternative.
IM (procaine penicillin)	6 lakh units (600,000 IU) IM once daily	Once daily	10–14 days	Alternative when IV and metronidazole are not available.

ℹ️ Note on metronidazole vs penicillin for tetanus: API Textbook of Medicine (current edition) and many Indian infectious disease experts now prefer metronidazole 500 mg IV TDS over penicillin G for tetanus — a Cochrane review showed reduced mortality with metronidazole compared to penicillin, possibly because penicillin’s GABA-antagonist activity in the CNS may worsen tetanus spasms. Penicillin G is now listed as an alternative in most current Indian guidelines, not first-line.

Secondary Indications — Adults Only (Off-label)

1. LEPTOSPIROSIS — SEVERE (Weil’s Disease)

OFF-LABEL but accepted standard practice in India

Salt form: CRYSTALLINE PENICILLIN (IV)

Dosing — Adults:

Route	Dose	Frequency	Duration	Notes
IV	1.5 MU (15 lakh units) IV every 6 hours (= 6 MU/day)	Every 6 hours	7 days	Standard regimen for severe leptospirosis. Alternative: ceftriaxone 1 g IV OD (equally effective, more convenient). For mild-moderate leptospirosis: doxycycline 100 mg BD oral × 7 days is first-line.

Evidence basis: Level of evidence: Moderate (supported by multiple clinical studies and WHO/ICMR guidelines). Ceftriaxone has equivalent efficacy and is increasingly preferred in Indian practice for convenience.

Indian source: ICMR Leptospirosis Treatment Guidelines; API Textbook of Medicine; Kerala State Leptospirosis Protocol (Kerala has the highest leptospirosis burden in India).

2. INTRAPARTUM GROUP B STREPTOCOCCAL (GBS) PROPHYLAXIS

OFF-LABEL but accepted standard practice in India (where GBS screening is performed)

Salt form: CRYSTALLINE PENICILLIN (IV)

Dosing — Intrapartum (during labour):

Route	Loading Dose	Maintenance	Duration	Notes
IV	5 MU (50 lakh units) IV at onset of labour or rupture of membranes	2.5–3 MU (25–30 lakh units) IV every 4 hours until delivery	Until delivery (discontinue after delivery)	Drug of choice for intrapartum GBS prophylaxis. Narrower spectrum than ampicillin (the alternative). ℹ️ GBS screening and intrapartum prophylaxis practice in India is less standardised than in Western countries. Universal GBS screening at 35–37 weeks is not routinely performed in most Indian centres. Prophylaxis is given based on risk factors (preterm labour, prolonged ROM >18 hours, intrapartum fever, previous infant with GBS disease, GBS bacteriuria in current pregnancy).

Evidence basis: Level of evidence: Strong (multiple RCTs and meta-analyses support intrapartum antibiotic prophylaxis for GBS; CDC/ACOG guidelines — adapted for Indian practice where GBS screening is performed).

Alternative for penicillin allergy: Cefazolin 2 g IV then 1 g IV every 8 hours (if non-anaphylactic allergy); clindamycin 900 mg IV every 8 hours (if anaphylactic allergy and GBS susceptible to clindamycin); vancomycin 1 g IV every 12 hours (if allergy AND clindamycin-resistant GBS).

Indian source: FOGSI guidelines on GBS prophylaxis (where adopted); IAP/NNF recommendations for GBS prevention.

3. ACTINOMYCOSIS

OFF-LABEL

Salt form: CRYSTALLINE PENICILLIN (IV) for initial phase; followed by oral amoxicillin

Dosing — Adults:

Phase	Route	Dose	Frequency	Duration
Initial (IV phase)	IV	18–24 MU/day (180–240 lakh units/day) in 6 divided doses	Every 4 hours	2–6 weeks (until clinical improvement)
Step-down (oral phase)	Oral amoxicillin	500 mg–1 g TDS	Three times daily	6–12 months total (prolonged oral therapy is essential to prevent relapse)

Evidence basis: Level of evidence: Weak (case series and expert consensus; no RCTs). Actinomyces israelii is universally susceptible to penicillin. Prolonged therapy is necessary due to the organism’s ability to form dense abscesses and sulphur granules with poor antibiotic penetration.

Indian source: API Textbook of Medicine; infectious disease specialist practice.

4. ANTHRAX — SYSTEMIC / INHALATIONAL (Bioterrorism / Occupational Exposure)

OFF-LABEL for the IV treatment component in current Indian practice (as ciprofloxacin + one or two additional agents is the current standard for systemic anthrax)

Salt form: CRYSTALLINE PENICILLIN (IV)

Dosing — Adults:

Route	Dose	Frequency	Duration	Notes
IV	4 MU (40 lakh units) IV every 4 hours (= 24 MU/day)	Every 4 hours	≥14 days (longer if meningitis is present)	⚠️ For systemic anthrax (including inhalational): current guidelines recommend ciprofloxacin or doxycycline as the primary agent, with crystalline penicillin (or ampicillin) as an adjunctive second or third agent in the multi-drug regimen. Penicillin monotherapy is inadequate for systemic anthrax (risk of inducible beta-lactamase production by some B. anthracis strains). For cutaneous anthrax (uncomplicated): oral amoxicillin or ciprofloxacin × 7–10 days is standard.

Evidence basis: Level of evidence: Moderate (guidelines-based; limited clinical data due to rarity of systemic anthrax; supported by CDC/WHO bioterrorism treatment protocols adapted for Indian use).

Indian source: NCDC Anthrax Treatment Module; ICMR infectious disease guidelines.

5. NEONATAL CONJUNCTIVITIS (OPHTHALMIA NEONATORUM) — GONOCOCCAL

OFF-LABEL but accepted standard practice in India

Salt form: CRYSTALLINE PENICILLIN (IV)

ℹ️ Due to rising gonococcal resistance to penicillin, ceftriaxone is now the standard treatment for gonococcal ophthalmia neonatorum in India and globally. Penicillin G is used ONLY if gonococcal susceptibility to penicillin is confirmed — this is increasingly rare.

Dosing — Neonates: See PAEDIATRIC DOSING section.

PAEDIATRIC DOSING (Specialist Only)

⛔ All paediatric use of benzylpenicillin — particularly IV crystalline penicillin at high doses and neonatal dosing — should be under specialist supervision (paediatrician, paediatric infectious disease specialist, neonatologist, or paediatric cardiologist for RF/RHD).

General Notes:

⚠️ SALT FORM VERIFICATION IS CRITICAL IN PAEDIATRICS. The consequences of administering the wrong salt form are amplified in children. Inadvertent IV administration of benzathine or procaine penicillin in a child can be fatal. Always verify the vial label at the bedside.
Safety monitoring requirements specific to paediatric use:
- Monitor IV site for extravasation and phlebitis (crystalline penicillin is irritant to veins — particularly in small paediatric veins)
- Monitor for seizures at high IV doses — children with renal impairment, CNS infections, or dehydration are at higher risk of penicillin neurotoxicity
- Monitor serum electrolytes at high IV doses — sodium load (from sodium salt) can be significant in small infants
- ⚠️ Monitor for hyperkalaemia if using the potassium salt (less common in India but may be supplied) — particularly in neonates and infants with immature renal function
- ⚠️ Anaphylaxis preparedness must be available before any penicillin injection — adrenaline (epinephrine) dose in children: 0.01 mL/kg of 1:1000 (adrenaline 1 mg/mL) IM, maximum 0.3 mL in children <6 years, 0.5 mL in children ≥6 years
- For benzathine penicillin IM: observe for 30 minutes after injection for anaphylaxis and Hoigné reaction (see adult section — Hoigné reaction can also occur in children, presenting as acute distress, inconsolable crying, and bizarre behaviour)
Minimum age limits:
- Crystalline penicillin (IV/IM): Can be used from birth (including preterm neonates) — see Neonatal Dosing below
- Procaine penicillin (IM): Generally used from birth; some guidelines avoid in preterm neonates due to concerns about procaine toxicity (seizures from procaine component) — crystalline penicillin is preferred in neonates
- Benzathine penicillin (IM): Used from infancy (>1 month) for RF prophylaxis and congenital syphilis prevention; can be used in neonates (see congenital syphilis dosing below)
Minimum weight:
- Benzathine penicillin RF prophylaxis dose transition: <27 kg → 6 lakh units (600,000 IU); ≥27 kg → 12 lakh units (1.2 MU)
- For all other indications, dosing is weight-based (units/kg)
Formulation suitability for children:
- Crystalline penicillin (powder for injection): Suitable — allows accurate weight-based dose calculation after reconstitution. Available in 5 lakh and 10 lakh unit vials (appropriate for paediatric dosing). Requires reconstitution — see Reconstitution section.
- Procaine penicillin (suspension for IM): Suitable for IM injection in children. ⚠️ Large-volume IM injections are painful — divide dose between two injection sites if volume exceeds 1 mL in infants or 2 mL in older children.
- Benzathine penicillin (suspension for IM): Suitable for children ≥1 month. ⚠️ The suspension is viscous and requires a 21G or larger needle and slow, deep IM injection into a large muscle mass (anterolateral thigh in infants <2 years; gluteal/ventrogluteal in children ≥2 years). The injection is painful — distraction techniques, EMLA cream (applied 60 minutes prior), and caregiver support are recommended.
- No oral formulation exists — this is a significant practical limitation. For children who need oral antibiotic step-down, switch to oral amoxicillin (suspension available in India — palatable formulations widely available) or oral phenoxymethylpenicillin (Penicillin V) (less palatable — bitter taste; suspension available but less commonly stocked in India; tablet formulation available for older children).
Palatability: Not applicable — no oral formulation. However, IM benzathine penicillin injections are notoriously painful (viscous suspension, large volume, deep IM site) — this is a major adherence barrier for RF prophylaxis in children. Strategies to improve adherence: EMLA cream before injection, use of 21G 1.5-inch needle, slow injection (≥2 minutes), warming the vial to room temperature before injection, and psychological support.
Age-specific pharmacokinetic differences affecting dosing:
- Neonates (especially preterm): Markedly prolonged half-life (see Population PK in Part 1). Require REDUCED dosing frequency (every 8–12 hours in preterm neonates instead of every 4–6 hours in older children).
- Infants (1–12 months): Half-life approaches adult values by 3–6 months. Standard weight-based dosing with every-4–6-hour frequency is appropriate.
- Children (1–12 years): Pharmacokinetics similar to adults on a per-kg basis. Weight-based dosing applies.
- Adolescents (≥12 years or ≥40 kg): Transition to adult dosing.

Dosing method: Weight-based (units/kg) — mandatory for all paediatric dosing of crystalline and procaine penicillin. Fixed dosing for benzathine penicillin (weight-bracket-based: <27 kg vs ≥27 kg).

Adolescent transition: Children ≥12 years AND ≥40 kg may use adult dosing. For benzathine penicillin RF prophylaxis, the transition from 6 lakh to 12 lakh units occurs at ≥27 kg (not age-based).

Neonatal Dosing (<28 days of life)

⛔ Neonatal use — NICU / neonatal unit supervision only

Key neonatal pharmacokinetic principles:

Half-life of benzylpenicillin in neonates is gestational age-dependent:
- Preterm <29 weeks gestation (first week of life): t½ ~6–10 hours
- Preterm 29–36 weeks (first week of life): t½ ~4–6 hours
- Term ≥37 weeks (first week of life): t½ ~2–3 hours
- By day 14 of life (term neonate): t½ ~1.5 hours (approaching infant values)
Immature renal tubular secretion (OAT1/OAT3 transporters) is the primary reason for prolonged half-life
Dosing intervals must be EXTENDED in preterm neonates to avoid accumulation

1. NEONATAL SEPSIS / MENINGITIS — Empirical Therapy

Salt form: CRYSTALLINE PENICILLIN SODIUM (IV)

⚠️ Benzylpenicillin (penicillin G) + gentamicin is the WHO-recommended empirical first-line regimen for suspected neonatal sepsis. This is the standard regimen used in Indian NICUs and is endorsed by the National Neonatology Forum (NNF) and IAP Neonatology Chapter.

Dosing — Neonates:

Gestational Age / Postnatal Age	Dose (IV)	Frequency	Notes
Preterm <32 weeks, postnatal age 0–7 days	25,000–50,000 units/kg/dose	Every 12 hours	Lower dose (25,000 units/kg) for sepsis without meningitis; higher dose (50,000 units/kg) for suspected meningitis.
Preterm <32 weeks, postnatal age 8–28 days	25,000–50,000 units/kg/dose	Every 8 hours	Renal maturation allows slightly more frequent dosing.
Preterm 32–36 weeks, postnatal age 0–7 days	25,000–50,000 units/kg/dose	Every 8 hours
Preterm 32–36 weeks, postnatal age 8–28 days	25,000–50,000 units/kg/dose	Every 6 hours
Term ≥37 weeks, postnatal age 0–7 days	25,000–50,000 units/kg/dose	Every 8 hours
Term ≥37 weeks, postnatal age 8–28 days	25,000–50,000 units/kg/dose	Every 6 hours	Approaching standard infant frequency.

ℹ️ Meningitis dosing (all neonates): Use the higher dose (50,000 units/kg/dose) to maximise CSF penetration. Some neonatal protocols use up to 75,000–100,000 units/kg/dose for confirmed GBS meningitis — specialist guidance required.

⚠️ Combination with gentamicin: The standard neonatal sepsis regimen is benzylpenicillin + gentamicin. Gentamicin dosing in neonates is also gestational age-dependent and requires TDM (therapeutic drug monitoring). See gentamicin monograph (separate). ⚠️ Do NOT mix penicillin and gentamicin in the same IV line — they are physically incompatible (aminoglycosides are inactivated by penicillins).

Indian source: NNF (National Neonatology Forum) Protocol for Management of Neonatal Sepsis; IAP-NNF Evidence-Based Clinical Practice Guidelines on Neonatal Sepsis (2021); WHO Pocket Book of Hospital Care for Children (Indian adaptation); MoHFW Facility-Based Integrated Management of Neonatal and Childhood Illness (F-IMNCI).

2. CONGENITAL SYPHILIS — Treatment

Salt forms: CRYSTALLINE PENICILLIN (IV — preferred) or PROCAINE PENICILLIN (IM — alternative)

Dosing — Neonates:

Scenario	Salt Form	Route	Dose	Frequency	Duration	Notes
Confirmed or highly probable congenital syphilis (abnormal CSF, or physical signs, or reactive non-treponemal test with titre ≥4-fold greater than maternal titre)	Crystalline penicillin	IV	50,000 units/kg/dose	Every 12 hours (age 0–7 days); every 8 hours (age 8–28 days)	10 days	⚠️ IV crystalline penicillin is preferred because it achieves adequate CSF levels (important since neurosyphilis cannot be reliably excluded in neonates).
Same scenario — when IV not feasible	Procaine penicillin	IM	50,000 units/kg/dose	Once daily	10 days	⚠️ Procaine penicillin does NOT reliably achieve therapeutic CSF levels. If any CNS involvement is suspected, IV crystalline penicillin is mandatory.
Neonatal syphilis — low risk (normal physical exam, normal CSF, reactive non-treponemal test titre NOT ≥4-fold greater than maternal titre, mother adequately treated ≥4 weeks before delivery)	Benzathine penicillin	IM	50,000 units/kg as a SINGLE DOSE	Single dose only	Single injection	Alternative approach: some protocols treat all neonates born to syphilis-seropositive mothers with the 10-day regimen rather than risk under-treating. Decision depends on the reliability of maternal treatment documentation and neonatal evaluation.

Indian source: NACO Guidelines for Prevention of Parent-to-Child Transmission (PPTCT) of Syphilis; NNF protocols; WHO Congenital Syphilis Treatment Guidelines.

3. NEONATAL TETANUS

Salt form: CRYSTALLINE PENICILLIN (IV) — alternative to metronidazole

Dosing — Neonates:

Route	Dose	Frequency	Duration	Notes
IV	50,000 units/kg/dose	Every 12 hours (preterm) or every 8 hours (term)	10–14 days	⚠️ Metronidazole (7.5 mg/kg IV every 8 hours) is now the preferred antibiotic for neonatal tetanus (see adult tetanus notes — same rationale regarding GABA antagonism). Crystalline penicillin is the alternative if metronidazole is unavailable. Primary treatment: TIG (tetanus immunoglobulin) + supportive ICU care.

Indian source: IAP-NNF Guidelines; WHO Neonatal Tetanus Management; F-IMNCI.

Primary Indications — Paediatric (Approved / Standard in India)

1. RHEUMATIC FEVER — SECONDARY PROPHYLAXIS (Paediatric)

Salt form: BENZATHINE PENICILLIN (IM only)

Weight-based dosing — Paediatric:

Weight	Dose	Frequency	Notes
<27 kg	6 lakh units (600,000 IU) IM	Every 3 weeks (preferred) or every 4 weeks	Inject into anterolateral thigh (children <2 years) or ventrogluteal/dorsogluteal muscle (children ≥2 years). Use 21G needle, 1–1.5 inch length depending on child’s size.
≥27 kg	12 lakh units (1.2 MU) IM	Every 3 weeks (preferred) or every 4 weeks	Adult dose. Inject into gluteal muscle. Divide between two sites if volume is excessive for a single site.

Duration: Same age-dependent duration guidelines as for adults (see Primary Indication 1 in Part 2). RF in children is common in India — most patients begin prophylaxis in childhood and continue for years to decades.

Mandatory Clinical Notes (Paediatric-specific):

When to prefer: Benzathine penicillin IM is the ONLY recommended prophylaxis in children (same rationale as adults — guaranteed compliance, 100% bioavailability).
When NOT to use: True penicillin allergy (IgE-mediated). Alternative: oral erythromycin (20 mg/kg/day in 2 divided doses, max 250 mg BD). Penicillin allergy testing and desensitisation may be considered at tertiary centres.
NLEM status: ✅ NLEM-listed.
Specialist initiation: Diagnosis of RF (Jones Criteria) should be confirmed by a paediatrician or paediatric cardiologist. Echocardiography is MANDATORY for all children with suspected RF. Ongoing injections can be administered at PHC/CHC level or school health clinics — NVHCP promotes community-level delivery.
Indian source: IAP Guidelines on RF/RHD (2008, updated practice); NVHCP; API Textbook.
Key safety warning: ⚠️ Injection pain is a major adherence barrier in children. Strategies: EMLA cream 60 minutes before injection, use of a 21G needle (not smaller — smaller gauges increase injection time and may clog with viscous suspension), warm the vial to room temperature, inject slowly over ≥2 minutes, use the Z-track technique to reduce leakage, distraction techniques (play therapist, cartoons, parental comfort). Document injection site and rotate between buttocks. ⚠️ Post-injection observation for 30 minutes is MANDATORY in children.
Dose adjustment: No renal or hepatic adjustment needed for benzathine penicillin prophylaxis doses.

2. SYPHILIS — CONGENITAL (Paediatric — Beyond Neonatal Period)

Salt forms: CRYSTALLINE PENICILLIN (IV) or BENZATHINE PENICILLIN (IM)

Children aged 1 month to <12 years with congenital syphilis (diagnosed beyond neonatal period):

Scenario	Salt Form	Route	Dose	Frequency	Duration
Normal CSF	Benzathine penicillin	IM	50,000 units/kg as a single IM dose (max 2.4 MU)	Single dose	Single administration
Abnormal CSF or neurological involvement	Crystalline penicillin	IV	50,000 units/kg/dose IV every 4–6 hours	Every 4–6 hours	10–14 days

Indian source: NACO PPTCT guidelines; WHO congenital syphilis guidelines adapted for Indian practice.

3. BACTERIAL MENINGITIS — Paediatric (Meningococcal — Susceptible)

Salt form: CRYSTALLINE PENICILLIN (IV)

Dosing — Children ≥1 month to <12 years:

Route	Dose	Frequency	Duration	Notes
IV	50,000 units/kg/dose (some protocols use up to 66,000 units/kg/dose for meningitis)	Every 4 hours (= 6 doses/day = 250,000–400,000 units/kg/day)	7–10 days (meningococcal); 10–14 days (pneumococcal)	Maximum daily dose: 24 MU/day (adult ceiling). ⚠️ Empirical therapy for suspected bacterial meningitis in children in India is ceftriaxone 100 mg/kg/day (max 4 g/day) — NOT crystalline penicillin. Switch to penicillin only if culture confirms penicillin-susceptible organism.

Indian source: IAP Guidelines on Bacterial Meningitis; ICMR meningitis management guidelines; IAP Textbook of Pediatrics.

4. SEVERE INFECTIONS (Pneumonia, Cellulitis, Septicaemia — Penicillin-Susceptible Organisms)

Salt form: CRYSTALLINE PENICILLIN (IV) or PROCAINE PENICILLIN/FPP (IM)

Dosing — Children ≥1 month to <12 years:

Severity	Salt Form	Route	Dose	Frequency	Maximum	Notes
Severe (hospitalised)	Crystalline penicillin	IV	25,000–50,000 units/kg/dose	Every 4–6 hours (= 100,000–300,000 units/kg/day for non-CNS infections)	Max 24 MU/day	For pneumonia, severe cellulitis, septicaemia with penicillin-susceptible organisms. Step down to oral amoxicillin when clinically improving.
Moderate (IM feasible, IV not available)	Procaine penicillin or FPP	IM	50,000 units/kg/dose (procaine penicillin)	Once daily	Max 1.2 MU/day	⚠️ IM only. Useful in PHC/CHC settings. F-IMNCI (Indian MoHFW protocol) recommends IM procaine penicillin or FPP for severe pneumonia in children when IV access and referral are not immediately available.

Indian source: IAP Textbook of Pediatrics; F-IMNCI (MoHFW); WHO Pocket Book of Hospital Care for Children (Indian adaptation).

5. DIPHTHERIA — Paediatric

Salt form: CRYSTALLINE PENICILLIN (IV) or PROCAINE PENICILLIN (IM)

Dosing — Children ≥1 month:

Route	Dose	Frequency	Duration	Notes
IV	25,000–50,000 units/kg/dose	Every 6 hours	14 days	⚠️ Antitoxin (DAT) is the PRIMARY treatment. Antibiotics are adjunctive.
IM (procaine penicillin)	25,000–50,000 units/kg/dose	Once daily	14 days	Alternative when IV not available.

Indian source: IAP Guidelines; NCDC Diphtheria Module; National Immunisation Schedule (prevention).

Secondary Indications — Paediatric (Off-label)

1. GROUP A STREPTOCOCCAL PHARYNGITIS / TONSILLITIS — TREATMENT (Primary RF Prevention)

OFF-LABEL for injectable benzylpenicillin for pharyngitis (oral penicillin V or oral amoxicillin is standard first-line). HOWEVER, a single IM dose of benzathine penicillin is a WHO/IAP-recommended alternative for primary RF prevention — and is effectively standard practice in India.

Salt form: BENZATHINE PENICILLIN (IM — single dose)

Dosing — Children:

Weight	Dose	Route	Frequency	Notes
<27 kg	6 lakh units (600,000 IU)	IM (single injection)	Single dose	Ensures complete treatment course in a single visit — no adherence concerns. Recommended by WHO and IAP when compliance with 10-day oral penicillin V course is uncertain (which is common in Indian outpatient settings).
≥27 kg	12 lakh units (1.2 MU)	IM (single injection)	Single dose	Adult dose.

Evidence basis: Level of evidence: Strong (WHO guidelines, IAP guidelines, multiple RCTs demonstrating equivalent or superior GAS eradication rates with single-dose IM benzathine penicillin compared to 10-day oral penicillin V).

ℹ️ Oral alternatives for GAS pharyngitis (first-line in most settings): Oral penicillin V (phenoxymethylpenicillin) 250 mg BD–TDS × 10 days; OR oral amoxicillin 50 mg/kg/day (max 1 g/day) in 2 divided doses × 10 days. Amoxicillin is preferred over penicillin V in Indian paediatric practice due to better palatability (strawberry-flavoured suspensions widely available) and once- or twice-daily dosing.

Indian source: IAP Guidelines on Acute Pharyngitis and RF Prevention (2017); WHO RF Prevention Guidelines.

2. LEPTOSPIROSIS — PAEDIATRIC (SEVERE)

OFF-LABEL but accepted standard practice in India

Salt form: CRYSTALLINE PENICILLIN (IV)

Dosing — Children ≥1 month:

Route	Dose	Frequency	Duration	Notes
IV	25,000–50,000 units/kg/dose	Every 6 hours	7 days	Alternative: ceftriaxone 50–80 mg/kg/day IV OD (often preferred for convenience).

Evidence basis: Level of evidence: Moderate (extrapolated from adult data; supported by paediatric case series and Indian treatment protocols).

Indian source: Kerala State Leptospirosis Protocol (paediatric section); IAP infectious disease guidelines.

MISSED DOSE / DELAYED DOSE GUIDANCE

Context-specific guidance by clinical use:

1. CRYSTALLINE PENICILLIN IV (Every 4–6 hours scheduled dosing — hospitalised patients):

Scenario	Guidance
Dose delayed by <2 hours	Administer as soon as possible. Resume the regular schedule.
Dose delayed by >2 hours	Administer immediately. Adjust subsequent doses to maintain the prescribed interval (every 4 hours or every 6 hours) from the time of the delayed dose — do NOT double up.
Dose missed entirely	Give the next scheduled dose at the correct time. Do NOT double the dose. Document the missed dose. ⚠️ For serious infections (meningitis, endocarditis), even a single missed dose can result in prolonged sub-MIC periods (due to the short half-life) — this may impair bactericidal activity. Alert the treating physician if doses are missed.
Multiple consecutive doses missed	Contact the treating physician immediately. Assess whether the missed doses have compromised treatment efficacy. No re-titration is needed — resume at the same dose. Consider whether continuous IV infusion may provide more reliable drug delivery (especially in ICU settings where nursing handover gaps may cause intermittent dose delays).

ℹ️ Key principle: Due to the very short half-life (30 minutes) and time-dependent killing pharmacodynamics, missed or delayed doses of crystalline penicillin are more consequential than for drugs with longer half-lives. Serum levels fall below the MIC within 2–4 hours of a missed dose — each missed dose creates a “window” of subtherapeutic exposure.

2. BENZATHINE PENICILLIN IM (Every 3 or 4 weeks — RF prophylaxis):

Scenario	Guidance
Injection delayed by ≤3 days (e.g., due to weekend, holiday, unavailability)	Give as soon as possible. Resume the regular 3-weekly or 4-weekly schedule from the date of the delayed injection.
Injection delayed by 4–7 days	Give as soon as possible. ⚠️ The patient may have had a period of subtherapeutic penicillin levels. Resume the regular schedule. Monitor for any symptoms of acute RF (fever, joint pain, carditis symptoms) for the next 4–6 weeks.
Injection delayed by >7 days (≥1 week overdue)	⚠️ Give the injection immediately. Resume the regular schedule. The patient was likely unprotected for the period of delay. If symptoms of acute RF develop, evaluate and treat accordingly. This is NOT a reason to restart the prophylaxis course — simply resume the schedule.
Injection missed for ≥1 month (non-adherence)	⚠️ Give the injection. Resume the schedule. Counsel the patient/family about the importance of regular injections. If multiple injections have been missed, refer to the treating cardiologist for reassessment (echocardiography to check for new valvular damage).

💡 Practical adherence strategy: Many Indian RF clinics issue an “injection card” with scheduled dates, phone reminders (SMS/WhatsApp), and caregiver education. Some NVHCP centres use community health workers (ASHAs) to track patients and remind them of injection dates. Encourage this approach.

3. BENZATHINE PENICILLIN IM (Weekly × 3 doses — Late Latent Syphilis Treatment):

Scenario	Guidance
Weekly dose delayed by <14 days	Give the dose and continue the schedule.
Weekly dose delayed by ≥14 days	⚠️ Restart the entire 3-dose course from the beginning (per NACO/WHO guidelines). The interruption may have allowed treponemal regrowth, necessitating a complete re-treatment.

4. Prolonged Non-Adherence / Drug Holiday Guidance:

Benzylpenicillin (all salt forms) does NOT carry risk of rebound effects, withdrawal syndrome, or immunogenicity upon discontinuation or resumption.

No withdrawal syndrome — can be stopped and restarted at any time.
No rebound infection — stopping prophylaxis increases the risk of new RF episodes or new GAS infection, but this is a loss of prophylactic protection, not a rebound phenomenon.
No re-titration needed — the drug can be resumed at the previous dose after any duration of non-adherence.
Not a biologic — no immunogenicity concern.

ℹ️ However, for RF prophylaxis, prolonged non-adherence (months to years of missed injections) significantly increases the risk of recurrent RF episodes and progressive valve damage. Counsel families about the critical importance of uninterrupted prophylaxis. Refer to cardiology for reassessment if prophylaxis has lapsed for >3 months.

RECONSTITUTION / ADMINISTRATION QUICK REFERENCE (For Nurses & Clinical Staff)

Crystalline Benzylpenicillin Sodium — Powder for Injection

Reconstitution:

Parameter	Details
Supplied as	White to off-white crystalline powder in glass vials. Available as 5 lakh units (500,000 IU), 10 lakh units (1 MU), 20 lakh units (2 MU), and 50 lakh units (5 MU) vials.
Diluent for reconstitution	Sterile Water for Injection (SWFI) — preferred for reconstitution. 0.9% Sodium Chloride (NS) — also compatible.
Incompatible diluents	⛔ Do NOT reconstitute with dextrose-containing solutions (D5W, D10W) for direct IV push — benzylpenicillin is less stable in dextrose solutions at high concentrations. Dextrose solutions are acceptable for FURTHER DILUTION for IV infusion (see below).
Reconstitution volumes and concentrations:

Vial Size	Diluent Volume to Add (SWFI or NS)	Approximate Final Concentration	Final Volume
5 lakh units (500,000 IU)	1.6 mL	~250,000 units/mL	~2 mL
10 lakh units (1 MU)	1.6 mL	~500,000 units/mL	~2 mL
	4 mL	~200,000 units/mL	~5 mL
20 lakh units (2 MU)	3.2 mL	~500,000 units/mL	~4 mL
	8 mL	~200,000 units/mL	~10 mL
50 lakh units (5 MU)	8 mL	~500,000 units/mL	~10 mL

ℹ️ Swirl gently until fully dissolved — do NOT shake vigorously (excessive foaming). Solution should be clear and colourless to pale yellow. Discard if turbid, deeply coloured, or contains particles.

Further Dilution for IV Infusion:

Parameter	Details
Compatible IV fluids	0.9% NaCl (Normal Saline) — preferred. 5% Dextrose (D5W) — acceptable for infusion (stability is adequate for the infusion duration if used within 1–2 hours). Ringer’s Lactate — compatible.
Recommended dilution for intermittent IV infusion	Dilute the reconstituted dose in 50–100 mL of NS or D5W for intermittent infusion.
Recommended dilution for continuous IV infusion	Dilute the total daily dose (e.g., 24 MU) in 500–1000 mL of NS and infuse continuously over 24 hours via infusion pump.
Final concentration range	Target: 100,000–500,000 units/mL for IV push; 10,000–50,000 units/mL for intermittent infusion; variable for continuous infusion (based on total daily volume).

Rate of Administration:

Route	Administration Guidance
IV bolus/push	Administer slowly over 3–5 minutes per dose (for doses ≤5 MU). For higher single doses (>5 MU), administer over 15–30 minutes as a short infusion to reduce the risk of electrolyte disturbance (sodium/potassium load) and seizures. ⚠️ Very rapid IV push can cause: transient hyperkalaemia (if potassium salt), seizures (especially in renal impairment), and local venous irritation.
IV intermittent infusion	Infuse over 15–30 minutes per dose. Use infusion pump or gravity drip with volume-limiting burette (Soluset) in paediatric patients.
IV continuous infusion (for endocarditis, meningitis, neurosyphilis — where 100% fT>MIC is desired)	Total 24-hour dose in 500–1000 mL NS. Run at a constant rate over 24 hours via infusion pump. Change the infusion bag every 12 hours (stability concern at room temperature — see below). Example: 24 MU/day → prepare 12 MU in 500 mL NS → run at ~21 mL/hr → change bag every 12 hours.
IM injection (crystalline penicillin)	Inject deep IM into a large muscle mass (gluteal in adults and older children; anterolateral thigh in infants/young children). Maximum volume per site: 2 mL (adults); 1 mL (infants). Slightly painful due to pH.

Weight-Based Dosing Calculation Example (Paediatric — IV):

Example: A 12 kg child with suspected meningococcal meningitis. Dose prescribed: 50,000 units/kg/dose IV every 4 hours.

- Required dose per administration = 12 × 50,000 = 600,000 units (6 lakh units)
- Using a 10 lakh unit (1 MU) vial reconstituted with 4 mL SWFI (= ~200,000 units/mL):
  - Volume to draw = 600,000 / 200,000 = 3 mL
- Dilute 3 mL in 20–50 mL NS and infuse over 15–30 minutes via Soluset/burette.
- Administer every 4 hours (6 times/day = total 3,600,000 units/day = 36 lakh units/day).

Stability After Reconstitution:

Condition	Stability
At room temperature (25°C)	⚠️ Use within 24 hours of reconstitution. Benzylpenicillin solution degrades progressively at room temperature — loss of potency accelerates above 25°C. In Indian conditions where ambient temperature often exceeds 30°C, use within 6–8 hours if unrefrigerated.
Under refrigeration (2–8°C)	Stable for up to 7 days when refrigerated. However, for clinical safety, use within 48 hours of reconstitution.
Continuous infusion bags	⚠️ Change every 12 hours at room temperature (degradation in solution at 25°C). If refrigerated bags are prepared in advance, allow to warm to room temperature before infusion.
Light protection	Not specifically required, but avoid prolonged exposure to direct sunlight (general good practice).

ℹ️ Indian climate note: In many Indian hospitals, especially in summer (ambient temperatures 35–45°C), reconstituted penicillin left at the bedside degrades rapidly. Ideally, each dose should be reconstituted fresh immediately before administration, or the reconstituted vial should be stored in the ward refrigerator and used within 24 hours.

Multi-Dose Vial Handling:

ℹ️ Crystalline penicillin vials in India are typically single-dose vials without preservative. If a dose requires only part of a reconstituted vial, the remainder should be:

Labelled with the drug name, concentration, date, and time of reconstitution
Stored in the refrigerator (2–8°C)
Used within 24 hours (refrigerated) or discarded
⚠️ For neonatal use: use a fresh vial for each dose — do NOT use partially used vials (contamination risk in immunocompromised neonates).

Benzathine Benzylpenicillin — Suspension for IM Injection

Reconstitution:

Parameter	Details
Supplied as	White powder for suspension in a glass vial. Reconstitute with the diluent provided (usually SWFI) or with 0.9% NaCl.
Diluent volume	For 12 lakh unit (1.2 MU) vial: Add approximately 4 mL SWFI. Shake vigorously until a uniform, milky-white suspension is formed. For 24 lakh unit (2.4 MU) vial: Add approximately 6–8 mL SWFI.
Final appearance	Milky-white, opaque suspension. ⚠️ If the suspension is clear or translucent, it is NOT benzathine penicillin — this indicates the wrong salt form has been reconstituted (crystalline penicillin forms a clear solution). This visual check is a critical safety measure.

Administration (IM only):

Parameter	Details
Route	⛔ IM ONLY — NEVER IV.
Needle	Use a 21G needle, 1.5 inches (for adults and older children). A smaller gauge (23G) may clog with the viscous suspension. In infants: 23G × 1 inch into anterolateral thigh may be used, but inject very slowly.
Site	Adults and children ≥2 years: ventrogluteal (preferred) or dorsogluteal muscle. Children <2 years: anterolateral thigh (vastus lateralis).
Technique	Draw up the suspension (shake vial immediately before drawing). Aspirate before injection (to confirm NOT in a blood vessel — though aspiration is no longer universally recommended, it remains standard practice for benzathine penicillin to avoid inadvertent IV delivery). Inject slowly over ≥2 minutes (reduces pain and risk of Hoigné reaction). Apply pressure to the site after withdrawal to prevent leakage of the viscous suspension.
Volume per site	Maximum 3–4 mL per injection site in adults; 1–2 mL per site in children. For 2.4 MU dose: divide between two injection sites (e.g., one injection in each buttock).
Post-injection observation	⚠️ Observe the patient for 30 minutes in the clinic/injection room after every benzathine penicillin injection. Have adrenaline (epinephrine) and anaphylaxis kit available.

Procaine Benzylpenicillin — Suspension for IM Injection

Reconstitution and administration principles are similar to benzathine penicillin (reconstitute to a suspension; IM ONLY; aspirate before injection; slow injection).

⛔ NEVER IV. Risk of Hoigné reaction (procaine-mediated pseudo-anaphylaxis) — acute psychomotor agitation, fear of death, visual/auditory hallucinations, seizures. Usually self-limiting (15–30 minutes) but extremely distressing. Caused by inadvertent intravascular injection of procaine or microembolisation. Not an allergic reaction — does NOT contraindicate future procaine penicillin use (though the patient may refuse further injections).

Y-site / Line Compatibility (Crystalline Penicillin IV):

Compatible (Y-site)	Incompatible — Do NOT Mix
Heparin	⛔ Aminoglycosides (gentamicin, amikacin, tobramycin) — penicillins chemically inactivate aminoglycosides when mixed in the same solution or Y-site. Administer through separate IV lines or flush the line with at least 20 mL NS between penicillin and aminoglycoside.
Potassium chloride (in IV fluid)	Sodium bicarbonate (alkaline solutions accelerate penicillin hydrolysis)
Hydrocortisone (some compatibility data)	Metronidazole (limited compatibility data — avoid mixing)
Ranitidine	Amphotericin B
Normal saline flush	Blood products — do NOT administer through the same line as blood

⚠️ Penicillin-aminoglycoside incompatibility is the MOST clinically important IV compatibility issue for this drug. In neonatal sepsis protocols (penicillin + gentamicin), these MUST be given through separate lines or with a thorough NS flush between drugs. Mixing them in the same bag or syringe will result in inactivation of the aminoglycoside and potential treatment failure.

Special Administration Notes:

Parameter	Details
Filter requirements	No specific in-line filter required for IV crystalline penicillin.
Flush line	Flush with 5–10 mL NS before and after IV administration (especially if alternating with aminoglycosides in the same line).
Extravasation risk	LOW — crystalline penicillin is NOT a vesicant. However, concentrated solutions are irritant to peripheral veins and may cause phlebitis with prolonged peripheral IV administration. Consider central line for courses >3–5 days at high doses (endocarditis, neurosyphilis).
IM injection notes (crystalline)	Painful injection. Rotate sites. Maximum 2 mL per site.
Enteral tube	Not applicable — no oral formulation.

Cold-Chain Drug Guidance:

Not applicable for storage — all benzylpenicillin formulations (powder) are stored at room temperature (below 30°C), protected from moisture. No cold-chain requirement for the powder.

However, reconstituted solutions of crystalline penicillin should be refrigerated if not used immediately (see Stability above). In Indian hospitals without reliable ward-level refrigeration, reconstitute fresh for each dose.

Storage Summary:

Formulation	Storage
Crystalline penicillin (unopened powder vial)	Room temperature, below 30°C, protect from moisture.
Crystalline penicillin (reconstituted)	Use immediately if possible. If stored: refrigerate (2–8°C), use within 24–48 hours.
Benzathine penicillin (unopened powder vial)	Room temperature, below 30°C, protect from moisture.
Benzathine penicillin (reconstituted suspension)	Use immediately after reconstitution. Do NOT store reconstituted suspension.
Procaine penicillin (unopened powder/suspension)	Room temperature, below 30°C, protect from moisture.
Procaine penicillin (reconstituted suspension)	Use immediately.

RENAL ADJUSTMENT

eGFR formula specification: Dose adjustment recommendations for benzylpenicillin are based on general renal pharmacokinetic principles rather than formal manufacturer-sponsored renal dosing studies. Cockcroft-Gault CrCl or CKD-EPI eGFR can be used interchangeably for clinical decision-making.

Key pharmacokinetic consideration: Approximately 60–90% of benzylpenicillin is excreted renally — predominantly via active tubular secretion (OAT1/OAT3). In renal impairment, clearance is markedly reduced and half-life is prolonged (from 30 minutes to 4–10 hours in severe CKD). Drug accumulation at high doses leads to neurotoxicity — the most important clinical consequence of renal dose adjustment failure.

⚠️ Penicillin neurotoxicity presents as: myoclonus (muscle jerking), seizures (focal or generalised), confusion, encephalopathy, and hallucinations. Risk is directly proportional to: (a) total daily dose; (b) degree of renal impairment; © CSF penetration (inflamed meninges → more drug in CNS). The mechanism involves GABA-A receptor antagonism by penicillin at high CNS concentrations.

Adjustment applies to CRYSTALLINE PENICILLIN (IV/IM) at HIGH DOSES only:

eGFR (mL/min)	Dose Adjustment	Notes
>60	No adjustment required. Standard dosing applies.	Full doses for all indications.
30–60	No routine adjustment for standard doses (≤12 MU/day). For high-dose regimens (>12 MU/day — meningitis, endocarditis): Consider reducing daily dose by 25% OR extending the dosing interval from every 4 hours to every 6 hours.	Monitor for neurotoxicity (myoclonus, seizures).
15–30	⚠️ Reduce dose by 25–50% OR extend dosing interval to every 6–8 hours. For high-dose regimens: use maximum 50–75% of the standard daily dose.	⚠️ Significant accumulation risk. Monitor closely for neurotoxicity. Check electrolytes (sodium load from the sodium salt; potassium load from the potassium salt).
<15 (non-dialysis)	⚠️ Reduce dose to 25–50% of standard AND extend interval to every 8–12 hours. For endocarditis/meningitis (where adequate drug levels are essential): specialist input required — balance neurotoxicity risk against need for therapeutic efficacy.	⚠️ High risk of neurotoxicity and electrolyte disturbance. Monitor serum creatinine, electrolytes (Na⁺, K⁺), and neurological status (myoclonus, seizures) daily.
Haemodialysis	✅ Benzylpenicillin IS removed by haemodialysis. Give a supplemental dose after each HD session — typically 50–75% of the standard dose post-dialysis.	Schedule the main dose to follow HD sessions. On non-dialysis days, use the dose/interval appropriate for eGFR <15.
Peritoneal dialysis	Partially removed by PD (less efficiently than HD). Use doses appropriate for eGFR <15. No specific post-PD supplemental dose is standard, but monitor clinical response and adjust.	Limited formal data.
CRRT	Drug clearance is increased compared to intermittent HD. Use 50–75% of the standard dose with standard dosing intervals (every 4–6 hours). Adjust based on clinical response and institutional CRRT protocol.	Consider continuous infusion for optimal drug delivery during CRRT.

Adjustment for BENZATHINE PENICILLIN (IM — RF prophylaxis, syphilis):

eGFR	Adjustment	Notes
All levels	No dose adjustment required.	Benzathine penicillin IM achieves very low peak serum levels (0.05–0.15 mcg/mL) — well below the threshold for neurotoxicity. Renal impairment prolongs the already-long duration of action (which is actually beneficial for prophylaxis). The risk of toxicity is negligible.

Adjustment for PROCAINE PENICILLIN (IM):

eGFR	Adjustment	Notes
>30	No adjustment required.
15–30	Use with caution. Consider reducing frequency to alternate-day dosing if a multi-day course is needed.	Monitor for procaine toxicity (CNS excitation, seizures) in addition to penicillin accumulation.
<15	⚠️ Avoid if possible. If no alternative, use alternate-day dosing with monitoring. Prefer IV crystalline penicillin (with renal dose adjustment) when feasible.

Augmented Renal Clearance (ARC): ⚠️ In young, non-elderly ICU patients (sepsis, trauma, burns, post-neurosurgery) with ARC (CrCl >130 mL/min), benzylpenicillin clearance is significantly increased. Standard doses may result in subtherapeutic levels, particularly for high-MIC organisms.

Strategy in ARC:

Continuous IV infusion of crystalline penicillin is the preferred approach in ARC — maintains 100% fT>MIC regardless of clearance rate.
Alternatively, increase dosing frequency to every 3–4 hours (from every 4 hours) if using intermittent dosing.
Do NOT simply increase the individual dose size (increases peak but does not extend the time above MIC — pharmacodynamically inefficient for time-dependent antibiotics).
Formal TDM for penicillin is not routinely available in India but is performed at select centres.

HEPATIC ADJUSTMENT

Primary clearance pathway: Renal excretion accounts for 60–90% of benzylpenicillin elimination. Hepatic metabolism is minimal (~10–20% — hydrolysis to inactive penicilloic acid). The drug does NOT undergo significant CYP450-mediated metabolism.

Dose adjustment in hepatic impairment:

Child-Pugh Class	Adjustment	Notes
A (Mild)	No adjustment required.
B (Moderate)	No adjustment required.
C (Severe)	No adjustment required.	ℹ️ Even in severe cirrhosis, the primary route of elimination (renal) is unaffected by hepatic impairment alone. If hepatorenal syndrome is present (concurrent renal impairment), adjust for the renal impairment component — see RENAL ADJUSTMENT.

No formal hepatic dosing data exists — none is needed, as hepatic metabolism plays a negligible role in benzylpenicillin clearance.

Active metabolite accumulation: Not applicable — no active metabolites.

Protein binding in hepatic impairment: Benzylpenicillin is ~60% protein-bound. In severe hypoalbuminaemia (cirrhosis, nephrotic syndrome), free drug fraction increases modestly — theoretically increasing both efficacy and toxicity risk. At standard doses, this is NOT clinically significant due to benzylpenicillin’s wide therapeutic index. At very high doses (>20 MU/day) in a patient with hypoalbuminaemia AND renal impairment, the combination of increased free fraction + reduced clearance could increase neurotoxicity risk — monitor accordingly.

Concurrent hepatotoxin note: Benzylpenicillin is NOT hepatotoxic. It does not cause drug-induced liver injury (DILI). No specific concern exists regarding additive hepatotoxicity when co-administered with hepatotoxic drugs (rifampicin, isoniazid, pyrazinamide, methotrexate, valproate, antiretrovirals).

However, one important clinical note: In patients with both hepatic impairment AND renal impairment (hepatorenal syndrome, advanced cirrhosis with CKD), the renal dose adjustment for benzylpenicillin is the critical consideration — hepatic adjustment is not independently required.

CONTRAINDICATIONS

⛔ Absolute contraindications — the drug must NEVER be used in these situations:

Contraindication	Clinical Rationale
⛔ Known IgE-mediated (Type I) hypersensitivity to any penicillin	Risk of anaphylaxis — a life-threatening emergency (bronchospasm, laryngeal oedema, hypotension, cardiovascular collapse, death). IgE-mediated reactions occur within minutes to 1 hour of penicillin administration. History of any of the following to any penicillin constitutes an absolute contraindication: anaphylaxis, angioedema, urticaria within 1 hour of administration, bronchospasm, hypotension. ⚠️ A history of a non-specific “rash” to penicillin in childhood (common parental report in India) does NOT automatically constitute a contraindication — most such rashes are viral exanthems or non-IgE-mediated reactions, and the patient may be safely re-challenged after proper allergy assessment. However, in the absence of formal allergy testing, err on the side of caution in routine practice. Formal penicillin allergy testing (skin prick test + intradermal test) is available at select Indian tertiary centres (AIIMS, PGI, CMC Vellore, select private allergy centres) and should be considered before labelling a patient as “penicillin-allergic” for life — because this label excludes them from the most effective treatments for RF prophylaxis, syphilis, and endocarditis.
⛔ IV administration of procaine benzylpenicillin or benzathine benzylpenicillin	⛔ FATAL. These depot formulations are suspensions (not solutions). IV injection causes embolic phenomena: pulmonary microembolism, coronary occlusion → cardiac arrest and death. Also causes Hoigné reaction (procaine) — acute psychomotor agitation, fear of death, seizures. These formulations are IM ONLY. This is NOT a drug allergy contraindication — it is a ROUTE contraindication.
⛔ Intrathecal administration of any benzylpenicillin formulation	⛔ Intrathecal injection of penicillin causes severe neurotoxicity — seizures, encephalopathy, arachnoiditis, death. Penicillin is a known GABA-A receptor antagonist at high CNS concentrations. Intrathecal injection achieves extremely high local CNS concentrations far exceeding the neurotoxicity threshold. NEVER administer by intrathecal or intraventricular route.

Allergy Cross-Reactivity — Beta-Lactam Antibiotics:

This is one of the most clinically important cross-reactivity considerations in medicine. The following summary reflects current evidence:

Drug/Class	Cross-Reactivity with Penicillins	Approximate Rate	Nature	Clinical Action
Other penicillins (amoxicillin, ampicillin, cloxacillin, piperacillin)	⛔ YES — very high	~100% (shared core beta-lactam + thiazolidine ring → identical major antigenic determinant)	Structure-based (predictable)	⛔ All penicillins are contraindicated if there is confirmed IgE-mediated allergy to any penicillin.
Cephalosporins (1st generation) (cephalexin, cefazolin)	YES — moderate	~1–2% cross-reactivity with current estimates (earlier estimates of 5–10% were based on methodologically flawed studies with impure cephalosporin preparations). First-generation cephalosporins have the highest structural similarity to penicillins (similar R1 side chain).	Structure-based (R1 side chain similarity)	⚠️ Avoid first-generation cephalosporins in patients with confirmed severe (anaphylactic) penicillin allergy. May be used with caution (supervised first-dose in a monitored setting) in patients with non-severe penicillin allergy (non-urticarial rash, remote history).
Cephalosporins (2nd–4th generation) (cefuroxime, ceftriaxone, cefotaxime, cefepime)	LOW	<0.5–1% cross-reactivity	Less structural similarity (different R1 side chains)	ℹ️ Generally considered safe to use in patients with penicillin allergy (including anaphylaxis) — BUT administer the first dose under observation (monitored setting with anaphylaxis kit available) in patients with a history of penicillin anaphylaxis. Ceftriaxone is the most commonly used alternative in Indian practice when penicillin allergy precludes penicillin use (e.g., meningitis, syphilis alternatives).
Carbapenems (meropenem, imipenem, ertapenem)	VERY LOW	<1% cross-reactivity	Different ring structure (carbapenem vs penam)	ℹ️ Safe to use in penicillin-allergic patients. First dose under observation in anaphylaxis history.
Monobactams (aztreonam)	NONE (no cross-reactivity)	0%	Completely different ring structure (monocyclic)	✅ Safe in penicillin-allergic patients — no cross-reactivity. However, aztreonam has very limited availability and clinical use in India.
Aminopenicillins with side chain similarity to specific cephalosporins (amoxicillin ↔ cephalexin/cefadroxil)	HIGHER within these specific pairs	~2–4%	Identical R1 side chain in specific pairs	⚠️ If allergy is specifically to amoxicillin (not penicillin G), cephalexin and cefadroxil carry a slightly higher cross-reactivity risk than other cephalosporins.

ℹ️ Practical approach in India for suspected penicillin allergy:

If history is vague (“my mother says I had a rash to penicillin as a child”): This is very common in Indian OPD. The vast majority of such patients are NOT truly penicillin-allergic. If the indication is critical (RF prophylaxis, syphilis in pregnancy), consider formal penicillin skin testing at a tertiary centre. If skin testing is negative, penicillin can be safely administered.
If history is convincing (documented anaphylaxis, angioedema, urticaria within 1 hour): Treat as true penicillin allergy. Avoid ALL penicillins. Use appropriate alternatives (erythromycin for RF prophylaxis; doxycycline for syphilis; ceftriaxone for meningitis/endocarditis — with first dose under observation).
If penicillin is ESSENTIAL and no alternative is adequate (e.g., syphilis in a pregnant woman with penicillin allergy): ⚠️ Penicillin desensitisation is indicated. This involves administering incrementally increasing doses of oral or IV penicillin over 3–4 hours in an ICU or monitored setting with full anaphylaxis management capability. Desensitisation protocols are available at AIIMS, CMC Vellore, PGI, and select tertiary centres. The desensitisation provides temporary tolerance — the patient must receive penicillin continuously after desensitisation (if treatment is interrupted, desensitisation is lost and must be repeated).

CAUTIONS

⚠️ HIGH-PRIORITY CAUTIONS (serious harm possible without active monitoring or dose adjustment):

Condition	Risk	Required Monitoring / Action
⚠️ Renal impairment (eGFR <30 mL/min)	⚠️ Penicillin neurotoxicity — the most important clinical risk of high-dose crystalline penicillin in renal failure. Presents as: myoclonus (early sign), generalised tonic-clonic seizures, encephalopathy (confusion, obtundation), hallucinations. Mechanism: accumulation of benzylpenicillin → high CNS concentrations → GABA-A receptor antagonism → neuronal excitotoxicity. Risk is proportional to dose and inversely proportional to renal function.	⚠️ Mandatory dose reduction — see RENAL ADJUSTMENT. Monitor neurological status daily (myoclonus is the earliest sign — ask about and examine for involuntary muscle jerking, especially in the face and extremities). If myoclonus or seizures develop: reduce dose immediately or stop; benzodiazepines for acute seizures (diazepam 5–10 mg IV or midazolam 2–5 mg IV). Check serum creatinine and electrolytes. Consider haemodialysis for severe toxicity.
⚠️ Electrolyte disturbance — sodium and potassium load at high doses	Each 1 MU (10 lakh units) of benzylpenicillin sodium contains ~1.7 mEq Na⁺. At 24 MU/day = ~41 mEq Na⁺/day (significant sodium load in heart failure, renal failure, or fluid-restricted patients). Benzylpenicillin potassium salt (less common in India): each 1 MU contains ~1.7 mEq K⁺. At 24 MU/day = ~41 mEq K⁺/day → ⚠️ risk of hyperkalaemia, especially in renal impairment, concurrent potassium-sparing diuretics, ACE inhibitors, or ARBs.	Monitor serum electrolytes (Na⁺, K⁺) daily at high doses (>12 MU/day). Preferentially use the sodium salt (standard in India) to avoid hyperkalaemia risk. If the potassium salt is supplied, verify with pharmacy and monitor K⁺ closely. In fluid-restricted patients (heart failure, renal failure), account for the sodium load in the daily fluid/electrolyte plan.
⚠️ History of seizure disorder or CNS lesion	Penicillin is a known proconvulsant (GABA-A antagonist at high CNS concentrations). Patients with pre-existing epilepsy, structural brain lesions, or prior CNS surgery have a lower seizure threshold. Risk is significantly amplified in the presence of concurrent renal impairment (drug accumulation → higher CNS levels).	Use the lowest effective dose compatible with the clinical indication. Ensure antiepileptic medications are continued. Monitor for new-onset seizures. Have benzodiazepines available.
⚠️ Concurrent aminoglycoside therapy (neonatal sepsis, endocarditis)	Physical incompatibility — penicillins chemically inactivate aminoglycosides when mixed in the same IV line or solution. This can result in subtherapeutic aminoglycoside levels → treatment failure. Also: both drugs are nephrotoxic at high doses (penicillin — interstitial nephritis; aminoglycoside — tubular toxicity).	⛔ NEVER mix in the same IV line, syringe, or infusion bag. Flush the line with ≥20 mL NS between penicillin and aminoglycoside administration. Use separate IV sites if possible. Monitor renal function and aminoglycoside levels (TDM) when used together.
⚠️ Hoigné reaction risk (benzathine and procaine penicillin IM)	Non-allergic pseudo-anaphylactic reaction occurring within seconds to minutes of IM injection of depot penicillin formulations. Presents with acute fear of death, visual and auditory disturbances, agitation, bizarre behaviour, tachycardia, sometimes seizures. Mechanism: microembolisation of depot suspension into small vessels → transient CNS effects (procaine component also contributes direct CNS excitation). NOT an IgE-mediated allergic reaction.	Distinguish from true anaphylaxis: Hoigné reaction does NOT include urticaria, angioedema, bronchospasm, or hypotension. Management: supportive — reassurance, calm environment, benzodiazepine (diazepam 5–10 mg IV or midazolam 2 mg IM) for severe agitation or seizures. Resolves spontaneously within 15–30 minutes. Does NOT contraindicate future penicillin injections (though the patient may refuse).
⚠️ Jarisch-Herxheimer reaction (syphilis treatment)	Occurs in 10–35% of patients treated for early syphilis. Onset 2–8 hours after first penicillin dose. Fever, rigors, headache, myalgia, hypotension (rarely), worsening of rash. Due to treponemal endotoxin-like lipoprotein release from dying organisms. In pregnant women: can cause uterine contractions, fetal distress, preterm labour.	Counsel the patient before treatment. Manage with paracetamol and fluids. Does NOT require discontinuation of penicillin. In pregnant women: administer penicillin under obstetric monitoring (CTG available). Consider premedication with prednisolone in late pregnancy (some protocols recommend prednisolone 40 mg daily for 3 days starting 24 hours before penicillin — evidence is limited but practice-based).

STANDARD CAUTIONS (conditions needing awareness but carrying lower risk):

Condition	Notes
Non-severe penicillin allergy history (delayed rash, GI upset)	Non-IgE-mediated reactions (maculopapular rash appearing >1 hour after administration, GI disturbance) do NOT constitute absolute contraindications but warrant documentation and awareness. May proceed with caution (first dose in a monitored setting with anaphylaxis kit available). Consider penicillin skin testing if the indication is long-term (RF prophylaxis).
Cystic fibrosis	Patients with CF have altered pharmacokinetics of many antibiotics (including penicillins) — increased Vd and increased renal clearance. Standard doses may be subtherapeutic. Higher doses and/or more frequent dosing may be needed — specialist input required.
Mononucleosis (Epstein-Barr virus infection)	⚠️ Ampicillin/amoxicillin cause a characteristic maculopapular rash in nearly 100% of mononucleosis patients. Benzylpenicillin (penicillin G) is LESS commonly associated with this rash than aminopenicillins, but the risk is not zero. If penicillin G is needed in a patient with EBV infection (uncommon scenario), monitor for rash. This is NOT an IgE-mediated allergy — it is a virus-drug interaction.
Heart failure / fluid overload	The sodium content of high-dose crystalline penicillin sodium (~41 mEq Na⁺/day at 24 MU/day) may exacerbate fluid retention. Account for sodium load in the daily fluid and electrolyte plan.
Patients on warfarin or other anticoagulants	High-dose IV penicillin can rarely cause coagulopathy (platelet dysfunction, interference with vitamin K-dependent clotting factors). Monitor INR more frequently if warfarin is co-prescribed. Clinically significant bleeding is rare.
Patients with implanted prosthetic devices receiving benzathine penicillin IM	Some older guidelines expressed theoretical concern about haematogenous seeding of prosthetic joints or valves from IM injection site bacteraemia. This concern is not supported by clinical evidence. Benzathine penicillin IM for RF prophylaxis should NOT be withheld from patients with prosthetic heart valves — they are among the highest-risk group for RF recurrence and NEED prophylaxis the most.
G6PD deficiency	No significant haemolytic risk with penicillins. Safe to use.
Prolonged courses (>2 weeks)	Monitor for Coombs-positive haemolytic anaemia (rare — reported with high-dose prolonged courses), interstitial nephritis (fever, rash, eosinophilia, rising creatinine), and superinfection (oral/vaginal candidiasis, C. difficile colitis).

PREGNANCY

Parameter	Details
Overall safety statement	✅ Safe in pregnancy — all trimesters. Benzylpenicillin (all salt forms) is one of the safest antibiotics in pregnancy. Extensive human experience over >75 years with no confirmed teratogenicity. Crosses the placenta but no adverse fetal effects at therapeutic doses. (Former US-FDA Category B — animal studies showed no harm; extensive human experience confirms safety.)
Teratogenicity window	No teratogenic risk at any gestational age. Safe throughout pregnancy including the critical organogenesis period (weeks 3–8 post-conception).
Trimester-specific risks	First trimester: No increased malformation risk. Safe. Second trimester: Safe. Third trimester: Safe. ⚠️ Jarisch-Herxheimer reaction in late pregnancy (when treating syphilis) can trigger uterine contractions, fetal distress, and preterm labour — administer under obstetric monitoring.
Specific indications in pregnancy	(a) Syphilis treatment in pregnancy — benzathine penicillin is the ONLY recommended treatment. No alternative is considered adequate for preventing congenital syphilis. ⛔ Doxycycline is contraindicated in pregnancy (fetal teeth/bone effects). ⛔ Azithromycin does NOT reliably cross the placenta to treat fetal infection. If the patient is penicillin-allergic: penicillin desensitisation is mandatory — then treat with penicillin. (b) RF prophylaxis — must NOT be interrupted during pregnancy. Continue benzathine penicillin IM every 3 weeks throughout pregnancy. © GBS intrapartum prophylaxis — crystalline penicillin IV during labour. (d) Any bacterial infection requiring penicillin — safe to use.
Preferred alternatives in pregnancy	No alternative is needed — benzylpenicillin is itself one of the safest antibiotics in pregnancy. If penicillin allergy precludes use: cephalosporins (cefazolin, ceftriaxone — with appropriate allergy cross-reactivity precautions), erythromycin, or azithromycin, depending on the specific infection.
What to monitor (mother)	Standard infection monitoring. For syphilis treatment: monitor for JHR (2–8 hours post-injection), uterine contractions, and fetal heart rate.
What to monitor (fetus)	For syphilis treatment in pregnancy: CTG monitoring during and after the first injection (JHR risk). Routine antenatal monitoring otherwise.
Pre-conception counselling	Not applicable — no pre-conception concerns with penicillin.
Contraception requirement	Not required.

Pregnancy Prevention Programme / Registry:

Not applicable — benzylpenicillin is safe in pregnancy and does not require a pregnancy prevention programme.

Fertility Effects:

No known effect on male or female fertility. Benzylpenicillin does not affect spermatogenesis, ovulation, or hormonal function. No washout period required before planned conception.

LACTATION

Parameter	Details
Compatibility with breastfeeding	✅ Compatible — safe during breastfeeding. Benzylpenicillin is excreted into breast milk in very small quantities. The relative infant dose (RID) is estimated at <1% of the maternal weight-adjusted dose — well within the safe range (<10%). The drug is poorly absorbed orally by the infant (acid-labile — destroyed in the infant’s stomach), further reducing effective infant exposure. Penicillins are among the safest antibiotics during lactation.
Drug levels in milk	Very low. Milk:plasma ratio is approximately 0.02–0.13 (very little drug transfers into milk). Combined with the infant’s poor oral absorption of benzylpenicillin, net infant exposure is negligible.
What to monitor in infant	Routine monitoring only. Theoretical concerns: (a) alteration of infant gut flora (may cause mild diarrhoea or oral thrush — very rare at the negligible exposure levels); (b) sensitisation to penicillin (theoretical — no clinical evidence that breast milk penicillin exposure causes later penicillin allergy).
Preferred alternatives during lactation	Not needed — benzylpenicillin is itself safe during lactation.
Timing advice	Not required — the drug is compatible with breastfeeding without timing restrictions.

Effect on milk production:

No known effect on milk production. Benzylpenicillin does not suppress or enhance lactation. No prolactin-related effects.

Temporary incompatibility guidance:

Not applicable — the drug is fully compatible with breastfeeding at all times. No need to withhold breastfeeding, pump and discard, or time doses around feeds.

ELDERLY

Definition: ≥60 years (Indian Census / National Programme for Health Care of the Elderly).

Parameter	Details
Recommended starting dose	Same as adult dosing for most indications — benzylpenicillin does not require age-based dose reduction per se. However, dose adjustment for renal function (which declines with age) is the primary consideration. Estimate eGFR in all elderly patients before initiating high-dose crystalline penicillin. In an elderly patient with eGFR 30–60 mL/min receiving high-dose therapy: reduce dose or extend interval as per RENAL ADJUSTMENT table.
Titration	Not applicable — penicillin dosing is weight/indication-based, not titrated.
Key risks in elderly	1. Renal function decline — the most important consideration. Age-related GFR decline (even without overt CKD) reduces penicillin clearance. A serum creatinine that appears “normal” in an elderly patient may mask a significantly reduced eGFR (due to lower muscle mass and creatinine generation). Always calculate eGFR — do not rely on serum creatinine alone. 2. Penicillin neurotoxicity — risk is amplified in elderly patients with renal impairment receiving high-dose IV crystalline penicillin. The ageing brain has reduced seizure threshold, and the combination of drug accumulation + CNS vulnerability makes elderly patients the highest-risk group for penicillin-induced seizures and encephalopathy. 3. IM injection challenges — elderly patients with sarcopenia (reduced muscle mass) may have less ideal IM injection sites for benzathine penicillin (gluteal muscle wasting). Consider the ventrogluteal site (better muscle bulk even in sarcopenic patients). Ensure adequate needle length to reach muscle (subcutaneous injection of benzathine penicillin is ineffective and may cause sterile abscess). 4. Phlebitis from IV crystalline penicillin — elderly patients with fragile peripheral veins are more susceptible to irritant phlebitis from concentrated penicillin solutions. Consider early placement of a PICC line or central line for courses >3 days. 5. Hypersensitivity — elderly patients may have been exposed to penicillin many times over their lifetime, potentially with undocumented allergic events. Take a thorough allergy history. 6. Superinfection — elderly patients (especially those on concurrent acid-suppressing drugs, immunocompromised, or hospitalised) are at higher risk of Clostridioides difficile infection during antibiotic therapy. Monitor stool frequency and character.

Anticholinergic Cognitive Burden (ACB):

ℹ️ Benzylpenicillin has NO anticholinergic properties. ACB Score: 0. No contribution to anticholinergic burden. No cognitive impairment risk from anticholinergic mechanism.

Beers Criteria / STOPP-START Relevance:

Benzylpenicillin is NOT listed in the Beers Criteria or STOPP/START criteria as a drug to avoid in elderly patients. It is a safe and appropriate antibiotic for elderly patients when used with renal dose adjustment.

Deprescribing Guidance:

Deprescribing is not applicable in the traditional sense — benzylpenicillin is used as a finite course (acute infection treatment) or as ongoing prophylaxis (RF). For RF prophylaxis in elderly patients, the question of whether to continue lifelong prophylaxis arises:

Scenario	Guidance
Elderly patient with RHD on lifelong benzathine penicillin prophylaxis	ℹ️ Current Indian guidelines recommend lifelong prophylaxis for patients with significant RHD (especially those with prosthetic valves or severe valvular disease). However, in elderly patients (>60 years) with stable mild RHD who have had no RF recurrence for >10 years, some cardiologists consider individualised discontinuation after shared decision-making. The risk of GAS pharyngitis (the trigger for RF) declines with age, and the risk-benefit of monthly injections may shift. There is no formal consensus on this — discuss with the treating cardiologist.
Elderly patient completing an antibiotic course	Standard antibiotic stewardship — stop at the prescribed duration. No tapering needed.

MAJOR DRUG INTERACTIONS

⛔ Interactions that are contraindicated, can cause life-threatening adverse events, or require mandatory dose adjustment / alternative drug selection.

Interacting Drug/Substance	Mechanism	Clinical Effect	Onset Type	Action Required
⛔ Aminoglycosides — physical incompatibility in IV solution (gentamicin, amikacin, tobramycin, streptomycin)	Chemical inactivation — the beta-lactam ring of penicillin nucleophilically attacks the amino groups of aminoglycosides, forming inactive amide bonds. This occurs when the two drugs are mixed in the same solution or run through the same IV line without flushing.	⚠️ Inactivation of the aminoglycoside → subtherapeutic aminoglycoside levels → treatment failure. The penicillin is also partially consumed but remains effective (it is present in much higher molar concentration). ℹ️ This is a physical/chemical incompatibility, NOT a pharmacological interaction. When given separately (different IV lines or with adequate flushing), the two drugs act synergistically against streptococci and enterococci — this synergy is the basis of combination therapy in endocarditis and neonatal sepsis.	Immediate — inactivation occurs within minutes of mixing	⛔ NEVER mix in the same IV bag, syringe, or Y-site without flushing. Administer through separate IV lines, OR flush the line with ≥20 mL NS between penicillin and aminoglycoside. In neonatal sepsis (penicillin + gentamicin protocol): give penicillin first, flush, then give gentamicin through the same line. If two IV sites are available, use separate sites. ℹ️ The synergistic pharmacodynamic effect is preserved when the drugs are given separately — only the physical mixing is contraindicated.
⚠️ Methotrexate	Benzylpenicillin (and other penicillins) competes with methotrexate for renal tubular secretion via OAT1/OAT3 transporters. This reduces methotrexate clearance and increases methotrexate plasma levels.	⚠️ Increased methotrexate toxicity — myelosuppression (pancytopaenia), mucositis, nephrotoxicity, hepatotoxicity. Particularly dangerous with high-dose methotrexate regimens (oncology).	Gradual onset — over 24–72 hours as methotrexate accumulates	⚠️ Avoid concurrent use of high-dose penicillin with high-dose methotrexate. If unavoidable (e.g., treating infection during methotrexate therapy): monitor methotrexate levels closely, monitor renal function, and monitor for methotrexate toxicity. Low-dose methotrexate (rheumatology — 7.5–25 mg/week) is less risky but still warrants monitoring.
⚠️ Warfarin and other vitamin K antagonists	(a) High-dose IV penicillin may inhibit platelet aggregation and suppress vitamin K-producing gut flora → additive anticoagulant effect. (b) Large-volume IV penicillin sodium infusions increase sodium and fluid load, potentially affecting warfarin distribution.	⚠️ Increased INR / bleeding risk — usually modest and clinically significant only at high penicillin doses (>12 MU/day) or prolonged courses.	Gradual onset — over days	⚠️ Monitor INR more frequently (every 2–3 days) when high-dose IV penicillin is co-administered with warfarin. Adjust warfarin dose as needed. Risk is LOW with benzathine penicillin IM (low systemic levels).
⚠️ Live vaccines (oral typhoid [Ty21a], BCG, oral polio)	Antibiotics may reduce the viability of live vaccine organisms during concurrent administration. Benzylpenicillin has activity against some organisms used in live vaccines.	⚠️ Potentially reduced vaccine efficacy. Primarily relevant for oral typhoid vaccine (Ty21a) — which is a live Salmonella typhi strain susceptible to penicillins.	Acute onset	⚠️ Complete the antibiotic course before administering oral typhoid vaccine — wait at least 3 days after the last penicillin dose. Injectable typhoid vaccine (Vi polysaccharide — Typhim Vi) is NOT affected (inactivated vaccine). BCG and OPV are less likely to be affected but separate by 3 days if possible.

Food-Drug Interactions:

Not applicable — benzylpenicillin has no oral formulation. No food-drug interactions exist for the injectable routes.

Herb-Drug and Traditional Medicine Interactions:

No documented clinically significant herb-drug interactions with benzylpenicillin. The drug is not metabolised by CYP450 enzymes, and its renal clearance mechanism is not significantly affected by commonly used Indian herbal preparations. However, as a general principle, patients taking traditional medicines should be asked about them to avoid unknown interactions.

MODERATE DRUG INTERACTIONS

Interactions that usually can be managed with monitoring or minor dose adjustment.

Interacting Drug/Substance	Mechanism	Clinical Effect	Onset Type	Action Required
Probenecid	Probenecid inhibits OAT1/OAT3-mediated renal tubular secretion of benzylpenicillin → reduced renal clearance → increased penicillin serum levels (approximately 2-fold increase in AUC) and prolonged half-life (from ~30 min to ~60–90 min).	Increased penicillin levels — this is a therapeutically BENEFICIAL interaction that was historically exploited to enhance penicillin efficacy before high-dose formulations were available. Currently used in the procaine penicillin + probenecid regimen for neurosyphilis (when IV crystalline penicillin is not feasible).	Acute onset — effect begins within 1–2 hours of probenecid administration	ℹ️ Intentional use: In the neurosyphilis regimen (procaine penicillin 2.4 MU IM daily + probenecid 500 mg QID × 10–14 days), this interaction is deliberately exploited to raise serum and CSF penicillin levels. Probenecid adherence is critical — missed probenecid doses render the regimen subtherapeutic. ℹ️ Unintentional co-prescribing: If a patient is already on probenecid for gout and receives penicillin, expect higher penicillin levels. Usually beneficial but may require penicillin dose reduction in renal impairment to avoid neurotoxicity from excessive accumulation.
Tetracyclines (doxycycline, tetracycline) and Chloramphenicol	Bacteriostatic antibiotics (tetracyclines, chloramphenicol) may theoretically antagonise the bactericidal action of penicillin. Penicillin requires actively dividing bacteria to exert its cell-wall-synthesis-inhibiting action; bacteriostatic drugs halt bacterial division.	Theoretical reduced bactericidal efficacy of penicillin. ℹ️ Clinical significance is debated — early in-vitro and animal studies demonstrated antagonism, but clinical evidence of treatment failure from this combination is limited. Modern infectious disease practice generally avoids concurrent use when possible but does not consider it absolutely contraindicated.	Acute onset (pharmacodynamic)	ℹ️ Avoid concurrent use when possible — use one or the other, not both. If both are genuinely needed (rare clinical scenario), administer penicillin first and tetracycline later (allow initial bactericidal killing before bacteriostasis). In practice, this interaction is rarely clinically relevant because penicillin and tetracyclines cover different organisms and are rarely co-prescribed for the same infection.
Oral contraceptives (combined OCP)	ℹ️ Historical concern — now largely DEBUNKED. Old teaching suggested that antibiotics (including penicillins) reduce OCP efficacy by disrupting gut flora that hydrolyse oestrogen conjugates → reduced enterohepatic circulation of ethinyl oestradiol → reduced OCP efficacy → contraceptive failure.	Current evidence: Large pharmacokinetic studies and population studies have found NO clinically significant reduction in OCP efficacy with penicillin co-administration. The only antibiotic confirmed to reduce OCP efficacy is rifampicin (a potent CYP3A4 inducer — different mechanism).	—	ℹ️ No additional contraception is needed when taking penicillin with combined OCPs. This is a common myth in Indian practice — many prescribers still advise “use barrier contraception while on antibiotics.” Current evidence does NOT support this advice for penicillins.
NSAIDs (indomethacin, ibuprofen, diclofenac)	NSAIDs may compete with penicillin for OAT-mediated renal tubular secretion → slightly increased penicillin levels. NSAIDs also reduce renal blood flow → decreased penicillin clearance.	Modestly increased penicillin levels. Usually clinically insignificant at standard penicillin doses. Potentially relevant at very high penicillin doses in patients with pre-existing renal impairment.	Gradual onset	ℹ️ No dose adjustment needed in most cases. Be aware of the interaction in patients receiving both high-dose penicillin AND NSAIDs with pre-existing renal impairment — monitor for penicillin neurotoxicity.
Potassium-sparing diuretics, ACE inhibitors, ARBs (when benzylpenicillin POTASSIUM salt is used)	Additive hyperkalaemia risk — potassium salt of benzylpenicillin provides ~1.7 mEq K⁺ per 1 MU. Combined with K⁺-retaining drugs, total potassium load may cause clinically significant hyperkalaemia.	⚠️ Hyperkalaemia — especially at high penicillin doses (>12 MU/day of the potassium salt).	Gradual onset (over days of high-dose treatment)	⚠️ Preferentially use benzylpenicillin SODIUM salt (standard in India). If potassium salt is used: monitor serum K⁺ daily. Avoid concurrent potassium supplements. Alert the prescribing team to the potassium content of each vial.
Cholestyramine / other bile acid sequestrants	Not applicable — benzylpenicillin is parenteral only (no oral absorption to interfere with).	None	—	Not applicable.

COMMON ADVERSE EFFECTS

ℹ️ Benzylpenicillin is one of the best-tolerated antibiotics in clinical use. Its adverse-effect profile is dominated by hypersensitivity reactions (immune-mediated — not dose-dependent) rather than dose-dependent pharmacological toxicity. At standard doses in patients with normal renal function, significant adverse effects are uncommon.

Frequency classification source: Derived from decades of clinical experience, post-marketing surveillance, CDSCO product inserts, and published pharmacovigilance data. Exact incidence percentages are difficult to establish for a drug in use since the 1940s — frequency bands are approximate.

Very Common (≥10%):

Adverse Effect	System	Notes
Injection site pain (IM — especially benzathine and procaine penicillin)	Local / Musculoskeletal	The most frequently reported adverse effect across all injectable penicillin formulations. Benzathine penicillin IM is particularly painful due to the viscous suspension and large volume. Pain at injection site is reported in virtually all patients (incidence approaches 100% for benzathine penicillin IM). This is the single biggest barrier to adherence for RF prophylaxis in India, particularly in children. Strategies to reduce pain: EMLA cream 60 minutes before injection, use 21G needle (not smaller — smaller gauges increase injection time), warm the vial to room temperature, inject slowly over ≥2 minutes, Z-track technique, lidocaine diluent reconstitution (see below). ℹ️ Lidocaine as diluent: Some Indian protocols reconstitute benzathine penicillin with 1% lidocaine instead of SWFI to reduce injection pain. This practice is common in paediatric rheumatology clinics. Evidence supports modest pain reduction. ⚠️ Ensure the patient has no lidocaine allergy before using this technique. Do NOT use lidocaine with adrenaline (epinephrine) as diluent.
Injection site induration / hardness (IM — depot formulations)	Local	Palpable lump at the injection site lasting days to weeks after benzathine or procaine penicillin IM. Due to the slow dissolution of the depot suspension. Usually painless after the initial 24–48 hours. Does NOT indicate infection or abscess unless accompanied by increasing pain, warmth, erythema, or purulent discharge. Advise the patient that a “lump” is expected.

Common (1–10%):

Adverse Effect	System	Notes
Diarrhoea	GI	Due to disruption of normal gut flora. Usually mild and self-limiting. More common with prolonged courses (>7 days) and high doses. Monitor for C. difficile infection if diarrhoea is severe, bloody, or persistent.
Nausea	GI	Mild. More common with IV administration (may be related to rate of infusion). Usually transient.
Maculopapular rash (non-urticarial, delayed)	Dermatological / Immunological	Occurs in approximately 2–5% of patients. Onset typically >72 hours after starting penicillin (delayed — Type IV hypersensitivity). Non-pruritic or mildly pruritic maculopapular eruption on trunk and extremities. ⚠️ This is a non-IgE-mediated reaction and does NOT indicate risk of future anaphylaxis. However, it is often misclassified as “penicillin allergy” in Indian medical records, resulting in lifelong avoidance of all penicillins — a significant problem for patients who later need penicillin for RF prophylaxis or syphilis. ℹ️ A delayed maculopapular rash should be documented as “non-severe delayed rash — NOT anaphylactic allergy” to avoid inappropriate penicillin avoidance in the future. Formal allergy assessment (skin testing) can clarify the situation.
Oral / vaginal candidiasis (thrush)	Infectious	Due to suppression of normal bacterial flora allowing Candida overgrowth. More common with prolonged courses and broad-spectrum penicillins (aminopenicillins > penicillin G). Benzylpenicillin’s narrow spectrum makes this less common than with amoxicillin/ampicillin, but it still occurs. Treat with topical antifungals (clotrimazole, nystatin).
Phlebitis / thrombophlebitis (IV site)	Local / Vascular	Occurs in approximately 5–10% of patients receiving IV crystalline penicillin via peripheral cannula. Due to the alkaline pH of reconstituted penicillin solution, local venous irritation, and repeated infusions through the same site. More common at higher concentrations and with prolonged peripheral IV access. Strategies: dilute adequately (infuse in ≥50 mL NS), rotate IV sites every 48–72 hours, consider midline catheter or PICC for courses >3–5 days.
Fever (drug fever)	Immunological	Non-infectious fever occurring during penicillin therapy (usually after 7–10 days of treatment). Part of a broader drug hypersensitivity syndrome. Diagnosis of exclusion — must rule out inadequately treated infection, abscess, or other causes of fever before attributing to drug fever. Resolves within 48–72 hours of stopping penicillin.
Eosinophilia	Haematological	Mild peripheral eosinophilia (>500/μL) may develop during prolonged penicillin courses. Usually asymptomatic and self-limiting. May herald more serious hypersensitivity (interstitial nephritis, serum sickness-like reaction) — monitor if >10% eosinophils or if accompanied by rash, fever, or rising creatinine.

Dose-Response Thresholds:

Adverse Effect	Dose Threshold
GI effects (diarrhoea, nausea)	More common at higher total daily doses (>12 MU/day) and with prolonged courses.
Phlebitis	More common with concentrated solutions (>100,000 units/mL for IV push) and at higher total daily doses.
Electrolyte disturbance (Na⁺/K⁺)	Clinically significant at ≥12 MU/day. See Cautions section.
Neurotoxicity (seizures, myoclonus)	Risk increases significantly at doses >20 MU/day, especially in renal impairment. See Serious Adverse Effects.

SERIOUS ADVERSE EFFECTS

⚠️ Rare but clinically important — may require immediate intervention, discontinuation, or hospitalisation.

Serious Adverse Effect	Approximate Frequency	Details	Action Required
⚠️ Anaphylaxis (IgE-mediated Type I hypersensitivity)	1–5 per 10,000 treatment courses (~0.01–0.05%); fatality rate ~1 per 50,000–100,000 treatment courses	The most feared adverse effect of penicillin. Onset: within seconds to 60 minutes of penicillin administration (any route — IV, IM, or even skin test). Classic features: urticaria, angioedema (swelling of face/lips/tongue/throat), bronchospasm (wheeze, dyspnoea), laryngeal oedema (stridor), hypotension, cardiovascular collapse, loss of consciousness, cardiac arrest. Risk is highest with parenteral administration (IV > IM). Risk does NOT increase with repeated penicillin courses — anaphylaxis can occur on first exposure (via prior environmental sensitisation) or on any subsequent exposure. ℹ️ The risk of fatal anaphylaxis must be weighed against the risk of NOT treating with penicillin (e.g., death from untreated meningitis, progressive RHD). For most serious infections, the benefit of penicillin vastly outweighs the small anaphylaxis risk — but preparedness for anaphylaxis management is mandatory.	⛔ Immediate recognition and treatment. Adrenaline (epinephrine) 1:1000 (1 mg/mL) IM — the first-line treatment for anaphylaxis. Adult dose: 0.5 mL (0.5 mg) IM into the anterolateral thigh. Paediatric dose: 0.01 mL/kg (0.01 mg/kg) IM, max 0.3 mL (<6 years), 0.5 mL (≥6 years). Repeat every 5–15 minutes if needed. Lay the patient flat with legs elevated (unless contraindicated by respiratory distress). Simultaneously: high-flow oxygen, IV access, IV fluids (NS 500–1000 mL bolus adult; 20 mL/kg child), IV antihistamine (chlorpheniramine 10 mg or diphenhydramine 50 mg), IV hydrocortisone 200 mg (adult) — for prevention of biphasic reaction. If bronchospasm: nebulised salbutamol. If cardiac arrest: CPR + adrenaline IV 1 mg. Observe for at least 6 hours post-anaphylaxis (risk of biphasic reaction in ~5–20%). Adrenaline availability: ✅ Widely available in India (ampoules stocked at virtually all healthcare facilities). Every injection room administering penicillin MUST have adrenaline and anaphylaxis kit immediately accessible. ⚠️ Report to PvPI.
⚠️ Serum sickness-like reaction (Type III hypersensitivity)	~1–2% (more common with prolonged courses >10 days)	Immune complex-mediated reaction. Onset: 7–21 days after starting penicillin (delayed). Presents as: fever, urticaria or maculopapular rash, arthralgia/arthritis (polyarticular, migratory), lymphadenopathy, proteinuria, and occasionally glomerulonephritis. Laboratory: low C3/C4 complement, elevated ESR, circulating immune complexes.	Stop penicillin. Supportive treatment: NSAIDs for joint pain, antihistamines for urticaria, short course of prednisolone (0.5–1 mg/kg/day × 5–7 days) for severe symptoms. Usually self-limiting within 1–3 weeks of drug discontinuation. Document as “serum sickness-like reaction to penicillin” — this does NOT indicate IgE-mediated allergy, but penicillin should be avoided in future unless formally tested. ⚠️ Report to PvPI.
⚠️ Penicillin neurotoxicity (seizures, myoclonus, encephalopathy)	Rare at standard doses; significant at high doses (>20 MU/day) in renal impairment	Dose-dependent adverse effect caused by GABA-A receptor antagonism at high CNS concentrations. Presents as: multifocal myoclonus (earliest sign — involuntary muscle jerking), generalised tonic-clonic seizures, confusion, lethargy, encephalopathy, hallucinations, coma. Risk factors: (a) high total daily dose (>20 MU/day); (b) renal impairment (reduced clearance → drug accumulation); © pre-existing CNS disease (meningitis, brain abscess — inflamed meninges increase CSF drug levels); (d) elderly patients; (e) intrathecal administration (absolute contraindication — see Contraindications). Occurs most commonly in endocarditis and neurosyphilis patients receiving 18–24 MU/day with concurrent renal function decline during the treatment course.	⛔ Stop or reduce the dose immediately. Seizure management: IV diazepam 5–10 mg (adult) or IV midazolam 2–5 mg. If refractory: IV phenytoin or levetiracetam. Check renal function — adjust penicillin dose for renal impairment. Consider haemodialysis for severe toxicity with renal failure (penicillin is dialysable). ⚠️ No specific antidote exists for penicillin neurotoxicity — management is dose reduction + supportive care. ⚠️ Report to PvPI.
⚠️ Acute interstitial nephritis (AIN)	Rare (~0.1–0.5% of prolonged courses)	Immune-mediated allergic reaction affecting renal tubules and interstitium. Onset: usually 1–4 weeks after starting penicillin. Classic triad (present in <30% of cases): fever, rash, eosinophilia. Laboratory: rising serum creatinine, eosinophiluria (urine eosinophils on Wright stain), mild proteinuria, sterile pyuria. May progress to acute kidney injury requiring dialysis if unrecognised.	Stop penicillin. Renal function usually recovers within weeks of drug discontinuation (most cases are reversible). Corticosteroids (prednisolone 1 mg/kg/day × 1–2 weeks then taper) may accelerate recovery in severe cases — evidence is mixed. Nephrology consultation for severe AKI. Avoid ALL penicillins in the future — the reaction is likely to recur on re-exposure. ⚠️ Report to PvPI.
⚠️ Coombs-positive haemolytic anaemia	Very rare (<0.1%) — reported with high-dose prolonged IV courses (>10 MU/day × >2 weeks)	Penicillin binds to red blood cell membranes → acts as a hapten → IgG anti-penicillin antibodies bind → complement activation → extravascular haemolysis. Presents as: progressive anaemia, jaundice (indirect hyperbilirubinaemia), reticulocytosis, positive direct Coombs test (DAT).	Stop penicillin. Haemolysis resolves within days to weeks of discontinuation. Transfusion for severe anaemia. Corticosteroids may help. Monitor Hb, reticulocyte count, LDH, haptoglobin, bilirubin. ⚠️ Report to PvPI.
⚠️ Clostridioides difficile infection (CDI)	Uncommon with narrow-spectrum penicillin G (more common with aminopenicillins and cephalosporins)	Antibiotic-associated disruption of gut flora → C. difficile overgrowth → toxin-mediated colitis. Presents as: watery diarrhoea (≥3 unformed stools/day), abdominal cramps, fever, leucocytosis. Severe cases: toxic megacolon, perforation, sepsis.	Stop the offending antibiotic if possible (or switch to a narrower-spectrum agent). Diagnose with stool C. difficile toxin assay (GDH + toxin A/B EIA or NAAT). Treat with: oral vancomycin 125 mg QID × 10 days (first-line for all severity in current guidelines) or oral/IV metronidazole 500 mg TDS × 10 days (second-line; still commonly used first-line in Indian practice due to cost). Fidaxomicin 200 mg BD × 10 days — available in India at limited centres, expensive. ⚠️ Report to PvPI for severe cases.
⚠️ Hoigné reaction (pseudo-anaphylaxis — depot penicillin formulations only)	1–3% of benzathine/procaine penicillin IM injections (some series report up to 5%)	See detailed description in Cautions section. Non-allergic, non-fatal acute psychomotor reaction occurring within seconds to minutes of IM depot penicillin injection. ⚠️ Must be differentiated from true anaphylaxis — Hoigné reaction does NOT have urticaria, angioedema, bronchospasm, or hypotension.	Supportive: reassurance, calm environment, benzodiazepine for severe agitation (diazepam 5–10 mg IV or midazolam 2 mg IM). Resolves spontaneously within 15–30 minutes. Does NOT contraindicate future penicillin use. ⚠️ Do NOT administer adrenaline unless anaphylaxis features are present.
Jarisch-Herxheimer reaction (syphilis treatment only)	10–35% of early syphilis treatment; ~2% of late syphilis treatment	See detailed description in Cautions section. Not a drug adverse effect per se — it is a host response to treponemal die-off.	Supportive: paracetamol, fluids. Does NOT require stopping penicillin. Obstetric monitoring in pregnant women.
Hyperkalaemia (potassium salt only — at high doses)	Dose-dependent; clinically relevant at >12 MU/day of the potassium salt	Each 1 MU potassium salt = ~1.7 mEq K⁺. At 24 MU/day = ~41 mEq K⁺/day. In patients with renal impairment, this can cause life-threatening hyperkalaemia (cardiac arrhythmias, cardiac arrest).	⚠️ Preferentially use the sodium salt (standard in India). Monitor serum K⁺ daily at high doses. ECG monitoring if K⁺ >5.5 mEq/L. Treat hyperkalaemia per standard protocol (calcium gluconate, insulin + glucose, salbutamol nebulisation, ion-exchange resin, dialysis).

Antidote / Reversal Information:

Toxicity	Antidote	Dose	Availability in India
Anaphylaxis	Adrenaline (epinephrine) 1:1000 IM	Adult: 0.5 mg IM; Paediatric: 0.01 mg/kg IM (max 0.3–0.5 mg). Repeat every 5–15 min.	✅ Widely available — must be present at every injection site.
Penicillin neurotoxicity (seizures)	Benzodiazepines (diazepam, midazolam)	Diazepam 5–10 mg IV (adult); 0.2–0.3 mg/kg IV (child). Midazolam 2–5 mg IV/IM.	✅ Widely available.
Hyperkalaemia (from potassium salt)	Calcium gluconate (cardiac membrane stabiliser) + insulin-glucose (shifts K⁺ intracellularly)	Calcium gluconate 10%: 10 mL IV over 2–5 min (adult). Insulin 10 units + 25 g glucose IV.	✅ Widely available.
Acute interstitial nephritis	No specific antidote. Corticosteroids may accelerate recovery.	Prednisolone 1 mg/kg/day × 1–2 weeks, then taper.	✅ Available.

⚠️ Report ALL serious adverse effects to nearest ADR Monitoring Centre under PvPI (Pharmacovigilance Programme of India) or via the ADR reporting form on CDSCO website: https://www.ipc.gov.in.

MONITORING REQUIREMENTS

Baseline (Before Starting)

Parameter	Grade	Details
Penicillin allergy history	MANDATORY	⚠️ Ask EVERY patient specifically: “Have you ever had a reaction to penicillin or any antibiotic? What happened? How soon after taking the medicine?” Document the response. Differentiate IgE-mediated (anaphylaxis, urticaria within 1 hour) from non-IgE (delayed rash, GI upset).
Renal function (serum creatinine, eGFR)	RECOMMENDED (MANDATORY for high-dose IV regimens >12 MU/day)	Essential for dose adjustment in high-dose regimens (endocarditis, meningitis, neurosyphilis). For benzathine penicillin IM prophylaxis or single-dose syphilis treatment, renal function check is not mandatory.
Serum electrolytes (Na⁺, K⁺)	RECOMMENDED for high-dose IV crystalline penicillin (>12 MU/day)	Baseline values important for detecting drug-related electrolyte disturbance. Correct hypokalaemia before starting (risk of penicillin neurotoxicity is potentiated by electrolyte abnormalities).
CBC with differential	RECOMMENDED	Baseline for detecting subsequent haematological adverse effects (eosinophilia, haemolytic anaemia, neutropaenia — all rare).
Anaphylaxis kit availability	MANDATORY	⚠️ Before EVERY penicillin injection (IV, IM — any salt form): confirm that adrenaline (epinephrine) injection, syringes, IV cannula, IV fluids, and resuscitation equipment are immediately available at the injection site.
Infection-specific investigations	MANDATORY — specific to the indication	Blood cultures (before starting — for endocarditis, sepsis, meningitis); LP (for meningitis, neurosyphilis); echocardiography (for endocarditis, RF); RPR/VDRL + treponemal test (for syphilis); wound cultures (for gas gangrene). See individual indications in Part 2.

Resource-limited setting surrogates:

Parameter	Surrogate
Renal function	If serum creatinine/eGFR cannot be measured: ask about known kidney disease, diabetes, oedema, reduced urine output. If high-risk factors for renal impairment exist, reduce dose empirically and refer for testing. For benzathine penicillin RF prophylaxis, renal function is not critical (very low systemic levels).
Serum electrolytes	If electrolytes cannot be measured at high IV doses: monitor for clinical signs — muscle weakness, palpitations, arrhythmia (hyperkalaemia); confusion, seizures (hyponatraemia or neurotoxicity). ECG if available.
Allergy assessment	Careful verbal history is the minimum acceptable standard. If history is unclear and the indication is critical, consider a supervised test dose (see below).

ℹ️ Supervised test dose protocol (when allergy history is uncertain and penicillin is strongly indicated): Administer 1/10 of the intended dose under close observation for 30 minutes. If no reaction, administer the remaining 9/10. This is NOT equivalent to formal skin testing or desensitisation — it is a pragmatic approach used in resource-limited Indian settings when formal allergy assessment is not available. This approach should ONLY be used for NON-anaphylactic allergy histories. If the history suggests anaphylaxis, formal skin testing or desensitisation at a tertiary centre is mandatory.

After Initiation / Dose Change

Timing	Monitoring	Details
During and 30 minutes after EVERY IM injection (benzathine/procaine penicillin)	Observation for anaphylaxis and Hoigné reaction	Patient must remain in the clinic/injection room. Have adrenaline and resuscitation equipment ready.
During IV infusion	IV site inspection; vital signs	Check for phlebitis, extravasation, infusion reactions. Monitor heart rate and blood pressure during infusion (especially first dose).
Daily (for high-dose IV courses)	Renal function (creatinine), serum electrolytes (Na⁺, K⁺), neurological status	⚠️ Check creatinine daily or every 48 hours during high-dose IV therapy (endocarditis, meningitis, neurosyphilis). Monitor for myoclonus (earliest sign of neurotoxicity). Monitor input-output chart (urine output).
Day 3–5 of treatment	Clinical response assessment	Is the patient improving? Are cultures becoming negative? If not improving, reassess diagnosis and antibiotic choice.
Weekly (for prolonged courses >2 weeks)	CBC with differential, renal function, LFT	Monitor for: eosinophilia (drug allergy), neutropaenia (rare — prolonged high-dose courses), rising creatinine (interstitial nephritis — fever + rash + eosinophilia + rising creatinine = classic triad), Coombs-positive haemolytic anaemia (progressive anaemia with reticulocytosis).

Long-Term / Maintenance Monitoring (RF Prophylaxis)

Timing	Monitoring	Details
At each injection visit (every 3–4 weeks)	Enquire about symptoms of RF recurrence (fever, joint pain, chorea, new cardiac symptoms), adverse effects (injection site problems), and adherence	Brief clinical assessment at each visit. Document injection given (date, dose, site, batch number).
Annually	Echocardiography	Assess progression or regression of valvular disease. Essential for guiding duration of prophylaxis and surgical planning.
As needed	ASO titre, CRP/ESR	Only if acute RF recurrence is suspected (not routine monitoring).

Therapeutic Drug Monitoring (TDM)

Not routinely performed for benzylpenicillin in Indian practice. Penicillin has a wide therapeutic index for most indications, and standard weight-based dosing is adequate.

Exceptions where TDM may be considered:

Refractory endocarditis with suspected subtherapeutic levels
ICU patients with augmented renal clearance (ARC) where continuous infusion is being used
Neonates with renal impairment receiving high-dose penicillin

TDM for penicillin is not widely available in India — limited to select tertiary centres with clinical pharmacology/pharmacokinetics laboratory services.

When to Stop Monitoring

Acute infection courses (5–14 days): Monitoring can be discontinued once the course is completed and clinical recovery is confirmed.
Prolonged courses (endocarditis — 4–6 weeks): Continue weekly monitoring throughout the course and for 1–2 weeks after completion (delayed adverse effects — interstitial nephritis, haemolytic anaemia).
RF prophylaxis (years to lifelong): Annual echocardiography and clinical assessment at each injection visit — indefinitely.

PATIENT COUNSELLING

Written in simple language that a doctor can directly convey to the patient during consultation.

What this medicine is for:

For RF prophylaxis (benzathine penicillin injection): “This injection protects your heart. You had a disease called rheumatic fever that can damage your heart valves. This injection, given every 3 weeks, prevents the fever from coming back and protects your heart from further damage. It is one of the most important medicines you will ever receive.”
For syphilis (benzathine penicillin injection): “This injection treats a sexually transmitted infection called syphilis. It is the best medicine for this infection and works with just one injection in most cases.”
For serious infection (crystalline penicillin IV): “This medicine is being given through your vein to fight a serious infection in your body. It needs to be given every few hours, day and night, to keep the medicine levels high enough to kill the germs.”

How to take it:

“This medicine is given as an injection — either into a vein (IV drip) or into the muscle of your buttock or thigh. There is no tablet or syrup form.”
For RF prophylaxis: “You need to come to the clinic every 3 weeks (21 days) for your injection. Mark the dates on a calendar or set a phone reminder. Do not skip or delay injections — even one missed injection puts your heart at risk.”

What to do if you miss a dose:

RF prophylaxis (benzathine penicillin): “If you miss your injection date, come as soon as possible — even if it is a few days late. The injection still works. Then resume your regular 3-week schedule. If you have missed many injections (more than 1 month), come to the clinic as soon as possible and tell the doctor. You may need a heart check-up.”
IV penicillin (hospital): “The nurses will give your medicine at the correct times. If you notice that an injection has been delayed or missed, tell the nurse or doctor immediately.”

Common side effects to expect:

“You may feel pain at the injection site — this is normal, especially with the long-acting injection given in the buttock. The pain usually lasts 1–2 days. You can apply a cold pack to the area. A hard lump may form at the injection site — this is also normal and will slowly disappear over days to weeks. You may have mild loose stools during treatment — drink plenty of water. You may develop a mild rash — tell your doctor about it, but it is usually not dangerous.”

Warning signs — come to hospital IMMEDIATELY if you notice:

"⚠️ Go to the hospital RIGHT AWAY if you develop any of the following during or within 1 hour after receiving the injection:

Difficulty breathing, feeling like your throat is closing
Swelling of your face, lips, tongue, or throat
A widespread itchy rash (hives/raised bumps) all over your body
Feeling faint, dizzy, or your heart racing very fast
Feeling a sudden intense fear or panic, seeing or hearing strange things (rare — tell the staff, they will help you)

During treatment with IV medicine (hospital), tell the nurse immediately if you notice:

Sudden jerking movements of your arms, legs, or face
A seizure (fit/convulsion)
Confusion or unusual drowsiness
Pain, swelling, or redness at the IV drip site"

Things to avoid:

“There are no special dietary restrictions with this medicine. You do not need to avoid any foods.”

Storage:

“This medicine is stored at the hospital or clinic. You do not need to keep it at home. If you have been given a vial to bring to the clinic, keep it at room temperature (below 30°C) in a dry, dark place — not in the fridge, and not in direct sunlight.”

Duration:

RF prophylaxis: “This injection is needed for many years — sometimes for life. Do NOT stop without your doctor’s permission, even if you feel perfectly well. Stopping puts your heart at serious risk.”
Syphilis: “Most cases need only one injection (or 3 weekly injections for some types). After treatment, you need blood tests at 6 months and 12 months to make sure the infection has been cured.”
Serious infections (IV): “The IV medicine is usually given for 1–6 weeks depending on the type of infection. The full course must be completed even if you feel better.”

Follow-up:

RF prophylaxis: “Come for your injection every 3 weeks. Have a heart check-up (echo test) once a year.”
Syphilis: “Come for a blood test (RPR/VDRL) at 3 months, 6 months, and 12 months after treatment to confirm cure. If you are pregnant, extra tests may be needed.”

Common patient questions addressed:

Question	Answer
“Can I take this with my other medicines?”	“This medicine is generally safe with most other medicines. Tell your doctor about all medicines you are taking. If you are on a blood-thinning medicine (warfarin), your doctor may need to check your blood more often.”
“Can I receive this injection during fasting (Ramadan/Navratri)?”	“Yes — an injection does not break a religious fast according to most Islamic and Hindu scholarly opinions. You can receive your injection during fasting periods without concern.”
“Will this affect my ability to drive or work?”	“No — this medicine does not cause drowsiness or dizziness. You can drive and work normally. You may have some pain at the injection site for a day or two.”
“Is this medicine habit-forming?”	“No — antibiotics are not addictive.”
“Can I stop once I feel better?”	“⚠️ NO — especially for RF prophylaxis. This injection is to PREVENT future disease, not to treat current symptoms. You must continue even when you feel perfectly well. For infection treatment, complete the full course as prescribed.”
“The injection is very painful — can anything be done?”	“Yes — your doctor or nurse can use a numbing cream (EMLA) on the skin before the injection. Warming the medicine to room temperature, using a slightly larger needle (21G), and injecting slowly also help reduce pain. Deep breathing or distraction (music, conversation) during the injection can help.”

Caregiver / Family Counselling:

"If you are caring for a child receiving regular penicillin injections for heart protection (RF prophylaxis):

Mark the injection dates on a calendar visible at home. Set a phone reminder.
⚠️ Never skip or delay an injection — each missed injection puts your child’s heart at risk of permanent damage.
After each injection, stay at the clinic for 30 minutes before going home. Watch for any unusual reaction (difficulty breathing, rash, swelling, extreme distress).
Apply EMLA cream (numbing cream) to the injection site 60 minutes before coming to the clinic — this significantly reduces pain for the child.
Reassure the child — the injection hurts briefly but protects the heart for life.
Keep the injection card safe — bring it to every appointment."

India-specific adherence support:

Concern	Guidance
Cost-driven non-adherence	“Benzathine penicillin is one of the cheapest medicines in India — usually ₹15–50 per injection. It is available at government hospitals for free. Ask about Jan Aushadhi pharmacies for the lowest price.”
Supply shortage (benzathine penicillin)	“⚠️ Benzathine penicillin has been in short supply in India in recent years. If your local pharmacy or hospital does not have it, ask the doctor about alternatives: (a) Check with other pharmacies, district hospital, or medical college hospital; (b) Oral penicillin V (Pen V) 250 mg twice daily can be used as a temporary substitute — but the daily tablets must be taken EVERY DAY without fail; © Your doctor may prescribe oral erythromycin as an alternative.”
Rural access	“If you live far from the clinic, ask whether an ASHA worker or ANM can visit your village to give the injection. Some NVHCP centres provide outreach injection services.”
Temperature-sensitive storage	“The injection powder does not need a fridge — keep it at room temperature, below 30°C, in a dry place.”
Stigma (syphilis)	“Syphilis is a common infection that can happen to anyone. It is completely curable with one injection. Treatment is confidential. Your partner should also be tested and treated.”

BRANDS AVAILABLE IN INDIA

Jan Aushadhi / PMBJP brands:

ℹ️ Benzylpenicillin injection (crystalline penicillin sodium) is listed in the PMBJP product catalogue. Jan Aushadhi stores stock this at significantly reduced prices.

Benzathine penicillin and procaine penicillin may also be available through PMBJP — verify current stock with local Jan Aushadhi stores, as availability fluctuates due to the chronic supply shortage.

Private / Commercial brands — Crystalline Penicillin (Benzylpenicillin Sodium Injection):

Brand Name	Manufacturer	Strength	Availability
Penidure C (crystalline component)	Wyeth/Pfizer (now various licensed manufacturers)	Part of combination vials (see FPP below)	Widely available
G-Penicillin / Penicillin G Sodium (generic)	Multiple Indian manufacturers (Alkem, Biochem, Cadila, Hindustan Antibiotics Ltd [HAL])	5 lakh units, 10 lakh units, 20 lakh units, 50 lakh units	Widely available — stocked in most government and private hospitals. HAL (public sector) supplies to government hospitals at subsidised rates.

Private / Commercial brands — Benzathine Penicillin (Benzathine Benzylpenicillin Injection):

Brand Name	Manufacturer	Strength	Availability
Penidure LA	Wyeth/Pfizer (now various manufacturers)	6 lakh units (600,000 IU); 12 lakh units (1.2 MU)	⚠️ INTERMITTENT AVAILABILITY. Chronic supply shortage since ~2016. Availability fluctuates — check with local pharmacy, district hospital, or state drug warehouse. When available, Penidure LA is the most recognised brand.
Pencom-12	Alkem Laboratories	12 lakh units (1.2 MU)	Moderate availability — urban pharmacies and hospital pharmacies.
Benzapen	Various manufacturers	12 lakh units; 24 lakh units	Limited availability — variable stocking.
Generic benzathine penicillin	Multiple manufacturers (HAL, others)	6 lakh units; 12 lakh units	Government hospital supply — availability varies by state and supply chain.

⚠️ SUPPLY CRISIS NOTE: Benzathine penicillin has been in chronic national and global shortage since approximately 2016–2017. Indian manufacturers have intermittently ceased production due to low profitability (drug is very cheap, production costs have risen, raw material supply is constrained). This shortage critically impacts RF prophylaxis and syphilis treatment programmes. The Indian government, WHO, and RHD advocacy groups have flagged this issue. Prescribers should:

Maintain awareness of current local supply status
Register patients with the state drug supply system for priority allocation
Have a contingency plan (oral penicillin V, erythromycin) ready for periods of unavailability
Report supply shortages to the state drug controller and CDSCO

Private / Commercial brands — Procaine Penicillin / Fortified Procaine Penicillin (FPP):

Brand Name	Manufacturer	Composition	Availability
Penidure Forte / FPP	Various manufacturers	Crystalline penicillin + Procaine penicillin (e.g., 1 lakh + 3 lakh = 4 lakh total)	Widely available — commonly stocked in PHC/CHC pharmacies and district hospitals. The most accessible injectable penicillin formulation in rural India.

CDSCO NSQ / Recall Alerts: Periodic Not of Standard Quality (NSQ) alerts for individual batches of generic penicillin products have been issued by CDSCO. Prescribers should verify against the latest CDSCO notifications at https://cdsco.gov.in. No widespread brand-level recall was identified at the time of this monograph.

PRICE RANGE (INR)

Prices as of June 2025. Verify current prices on NPPA/1mg/PharmEasy/Jan Aushadhi price lists as prices may change.

Formulation	Strength	Approximate Price Range (INR)	Notes
Crystalline penicillin (sodium) injection	5 lakh units (500,000 IU) vial	₹8–20 per vial	Very affordable. Government supply: ₹5–10.
	10 lakh units (1 MU) vial	₹12–30 per vial	Most commonly used. Government supply: ₹8–15.
	20 lakh units (2 MU) vial	₹20–50 per vial
	50 lakh units (5 MU) vial	₹40–80 per vial	Reduces number of vials for high-dose therapy.
Benzathine penicillin injection	6 lakh units (600,000 IU) vial	₹15–40 per vial	⚠️ Price may be higher during supply shortages.
	12 lakh units (1.2 MU) vial	₹25–60 per vial	Standard adult RF prophylaxis dose. Government supply: ₹15–25.
	24 lakh units (2.4 MU) vial	₹40–90 per vial	For syphilis treatment. Less commonly stocked.
Procaine penicillin / FPP injection	4 lakh units vial (FPP)	₹10–25 per vial	Very affordable. Widely available.
Jan Aushadhi	Various strengths	₹5–20 per vial (lowest available)

NPPA Price Control: ✅ Benzylpenicillin (all salt forms) is listed in NLEM India 2022 and is therefore subject to NPPA price control under the Drug Prices Control Order (DPCO). Ceiling prices are notified by NPPA.

PMBJP (Jan Aushadhi) availability: ✅ Available through Jan Aushadhi stores (crystalline penicillin; benzathine penicillin when in stock).

Per-Course Cost Estimates:

Scenario	Estimated Cost
RF prophylaxis — 1 year (benzathine penicillin 1.2 MU every 3 weeks × ~17 injections)	Branded: ₹425–1,020/year. Generic/Government: ₹255–425/year. Jan Aushadhi: ₹85–340/year. ℹ️ One of the most cost-effective interventions in medicine — preventing progressive RHD that would otherwise require ₹3–10 lakh valve surgery.
Syphilis (early) — single dose benzathine penicillin 2.4 MU	₹40–90 (single injection).
Syphilis (late latent) — 3 weekly doses of 2.4 MU	₹120–270 (3 injections).
Neurosyphilis — 14 days IV crystalline penicillin 24 MU/day	Crystalline penicillin: ~5 vials of 5 MU/day × 14 days = 70 vials × ₹40–80 = ₹2,800–5,600 (drug cost only; hospital admission costs additional).
Endocarditis — 4 weeks IV crystalline penicillin 18 MU/day	~4 vials of 5 MU/day × 28 days = 112 vials × ₹40–80 = ₹4,480–8,960 (drug cost only).
Meningitis — 7 days IV crystalline penicillin 24 MU/day	~5 vials of 5 MU/day × 7 days = 35 vials × ₹40–80 = ₹1,400–2,800 (drug cost only).

ℹ️ Cost-effectiveness note: Benzylpenicillin is among the cheapest and most cost-effective antibiotics in the world. For RF prophylaxis, the cost per DALY (disability-adjusted life year) averted is estimated at <$1 (approximately ₹80) — making it one of the most cost-effective health interventions globally. The annual cost of prophylaxis (₹250–1,000) is a tiny fraction of the cost of valve replacement surgery (₹3–10 lakh) that would be needed if RF recurs and RHD progresses.

CLINICAL PEARLS

💡 1. Three salts, three uses, three rules — learn them once, remember them for life. Crystalline penicillin = IV = serious infections (meningitis, endocarditis, neurosyphilis). Procaine penicillin = IM = moderate infections (pneumonia, cellulitis in PHC settings). Benzathine penicillin = IM = prophylaxis and slow-release treatment (RF, early syphilis). ⛔ Benzathine and procaine penicillin are NEVER IV. The milky-white suspension appearance of reconstituted benzathine/procaine penicillin vs the clear solution of crystalline penicillin is a critical visual safety check — if you see a milky suspension, it must NEVER go into a vein. [Evidence-based — pharmacological principle; reinforced by fatal case reports from Indian hospitals]

💡 2. Benzathine penicillin every 3 weeks, NOT 4 weeks, in India. The Indian consensus (ICMR, API Textbook, NVHCP, most Indian cardiology centres) favours the 3-weekly (21-day) regimen over the 4-weekly (28-day) regimen for RF secondary prophylaxis. Multiple Indian studies have demonstrated breakthrough RF episodes with the 4-weekly regimen. The 3-weekly interval ensures that serum penicillin levels remain above the treponemicidal/streptococcicidal threshold for the entire inter-dose period. [Evidence-based — Indian studies; ICMR recommendation; supported by API Textbook]

💡 3. Myth vs Fact — “If a patient says they are ‘allergic to penicillin,’ they can never receive penicillin again.”
Myth: A childhood history of “penicillin allergy” (usually a vague parental report of rash) permanently excludes the patient from all penicillins for life.
Fact: Studies consistently show that >90% of patients labelled “penicillin-allergic” are NOT truly allergic when formally tested (skin prick test + intradermal test). Most childhood “reactions” were viral exanthems misattributed to penicillin. The consequences of a false penicillin allergy label are severe — the patient is denied the ONLY effective drug for RF prophylaxis and syphilis treatment. Penicillin allergy de-labelling through formal skin testing is increasingly advocated and is available at select Indian tertiary centres (AIIMS, PGI, CMC Vellore). For critical indications (syphilis in pregnancy, RF prophylaxis), refer for allergy testing rather than accepting the label at face value. [Evidence-based — multiple allergy de-labelling studies; WHO/NICE guidance on penicillin allergy assessment]

💡 4. When benzathine penicillin is unavailable: the contingency plan. During supply shortages (frequent in India), use this hierarchy: (a) Source from alternative pharmacies, district drug warehouse, or neighbouring districts. (b) If unavailable anywhere: switch to oral penicillin V (phenoxymethylpenicillin) 250 mg BD — but ONLY if the patient can be reliably counselled to take it daily without fail (adherence rates with oral prophylaxis are very poor — <30% in Indian studies). © For penicillin-allergic patients or when all penicillin formulations are unavailable: oral erythromycin 250 mg BD. (d) As a last resort with specialist input: oral azithromycin 250 mg daily — limited evidence for RF prophylaxis, but used at some Indian centres during shortages. ⚠️ None of these alternatives are as effective as benzathine penicillin IM — resume injectable prophylaxis as soon as supply is restored. [Practice-based — Indian cardiology expert consensus during supply crises; NVHCP contingency guidelines]

💡 5. For endocarditis: continuous infusion may be superior to intermittent bolus dosing. Crystalline penicillin has a 30-minute half-life and time-dependent bactericidal activity. With intermittent bolus dosing every 4 hours, serum levels fall below the MIC for a significant portion of each dosing interval. Continuous IV infusion maintains 100% fT>MIC — pharmacodynamically optimal. Some Indian cardiology and infectious disease centres (AIIMS, CMC Vellore) use continuous infusion for penicillin-susceptible streptococcal endocarditis, particularly in ICU patients or when missed intermittent doses are a concern (nursing handover gaps, busy wards). Practical tip: Prepare 12 MU in 500 mL NS → run at ~21 mL/hr → change bag every 12 hours (stability). Total daily dose remains the same — only the delivery method changes. [Evidence-based — PK/PD principle; Practice-based — ICU protocols at select Indian centres]

💡 6. Cost of RF prophylaxis vs cost of valve surgery: the most cost-effective argument in Indian cardiology. Annual cost of benzathine penicillin prophylaxis: ₹250–1,000. Cost of mitral valve replacement surgery: ₹3–10 lakh (and ongoing costs of anticoagulation, follow-up, and potential re-operation). For every ₹1 spent on RF prophylaxis, an estimated ₹300–1,000 is saved in avoided surgical and healthcare costs. This is one of the most powerful health-economic arguments for any preventive intervention in India. Use this argument when counselling reluctant patients and families, when advocating for government programme funding, and when justifying stocking benzathine penicillin even during supply shortages. [Evidence-based — health economic analyses from Indian and global studies; WHO Best Buys for NCD Prevention]

VERSION

RxIndia v0.1 — 14 Mar 2026

REFERENCES

The following sources were used to compile this monograph. All text is originally written; no text was copied from any proprietary database.

CDSCO Product Insert — Penidure LA (benzathine benzylpenicillin) injection 6 lakh and 12 lakh units, Wyeth Ltd / Pfizer India (and subsequent licensed manufacturers). Approved indications, contraindications, dosing, and adverse effects. Most recently reviewed insert.
CDSCO Product Insert — Crystalline Penicillin G Sodium Injection IP, Hindustan Antibiotics Limited (HAL) and generic manufacturers. Approved indications, dosing, and adverse effects.
Indian Pharmacopoeia 2022 (IP 2022), Indian Pharmacopoeia Commission, Ghaziabad. 8th Edition. Monographs on Benzylpenicillin Sodium, Benzathine Benzylpenicillin, and Procaine Benzylpenicillin — specifications and official standards.
National List of Essential Medicines (NLEM) India 2022, Ministry of Health & Family Welfare, Government of India. Section 6.2 — Beta-lactam medicines: Benzylpenicillin (injection), Benzathine benzylpenicillin (injection), Procaine benzylpenicillin (injection) are listed.
Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 14th Edition (2023). Chapter 58: Penicillins, Cephalosporins, and Other Beta-Lactam Antibiotics. Pharmacology of benzylpenicillin — mechanism of action, spectrum, pharmacokinetics (including time-dependent killing, CSF penetration, renal excretion via OAT transporters), adverse effects, and drug interactions.
Harrison’s Principles of Internal Medicine, 21st Edition (2022). Chapters on: Infective Endocarditis; Meningitis and Encephalitis; Syphilis; Rheumatic Fever; Gas Gangrene and Clostridial Infections; Diphtheria; Tetanus; Leptospirosis. Treatment references for benzylpenicillin in each condition.
API Textbook of Medicine, 11th Edition (2019), Association of Physicians of India. Chapters on: Rheumatic Fever and RHD (RF prophylaxis — 3-weekly benzathine penicillin recommendation); Syphilis; Bacterial Meningitis; Infective Endocarditis; Tetanus (metronidazole preferred over penicillin); Diphtheria; Leptospirosis.
ICMR Guidelines on RF/RHD Prevention (2008). Recommends benzathine penicillin 1.2 MU IM every 3 weeks for secondary prophylaxis. Duration guidelines based on severity of carditis.
NVHCP (National Programme for Prevention and Control of RHD) — Operational Guidelines, Ministry of Health & Family Welfare, Government of India. RF/RHD registry, prophylaxis delivery protocols, and contingency guidance during benzathine penicillin supply shortages.
NACO (National AIDS Control Organisation) — STI/RTI Treatment Guidelines (Current Edition). Syphilis treatment protocols for all stages; congenital syphilis prevention; GBS prophylaxis guidance (where adopted).
WHO Guidelines for the Treatment of Treponema pallidum (Syphilis), 2016. Benzathine penicillin dosing for early syphilis, late syphilis, neurosyphilis, and congenital syphilis.
NNF (National Neonatology Forum) Protocol for Management of Neonatal Sepsis. Benzylpenicillin + gentamicin as empirical first-line regimen; gestational age-based dosing.
IAP-NNF Evidence-Based Clinical Practice Guidelines on Neonatal Sepsis (2021). Antibiotic dosing in neonates; benzylpenicillin gestational age-adjusted dosing tables.
IAP Textbook of Pediatrics, 6th Edition (2021), Indian Academy of Pediatrics. Sections on: neonatal sepsis, meningitis, RF/RHD, GAS pharyngitis, congenital syphilis, diphtheria. Dosing and management recommendations.
IAP Guidelines on Acute Pharyngitis and RF Prevention (2017). Benzathine penicillin single dose for GAS pharyngitis as RF prevention strategy.
WHO Pocket Book of Hospital Care for Children (Indian Adaptation), MoHFW. Antimicrobial dosing including penicillin formulations for paediatric infections.
F-IMNCI (Facility-Based Integrated Management of Neonatal and Childhood Illness), MoHFW. Procaine penicillin / FPP dosing for severe pneumonia in children at PHC/CHC level.
FOGSI Guidelines on Intrapartum GBS Prophylaxis — where adopted. Crystalline penicillin IV dosing for intrapartum prophylaxis.
NCDC (National Centre for Disease Control) Modules — Diphtheria treatment protocol; Meningococcal disease outbreak response; Anthrax treatment guidelines.
AHA/ESC Guidelines on Infective Endocarditis — adapted for Indian practice. Penicillin dosing for streptococcal endocarditis; gentamicin synergy protocols.
ICMR Leptospirosis Treatment Guidelines. Crystalline penicillin IV for severe leptospirosis; Kerala State Leptospirosis Protocol.
NPPA (National Pharmaceutical Pricing Authority) — Drug Prices Control Order (DPCO) schedule and ceiling price notifications. Benzylpenicillin (all salt forms) is NPPA price-controlled under NLEM scheduling.
PMBJP (Pradhan Mantri Bhartiya Janaushadhi Pariyojana) — Product catalogue reviewed. Benzylpenicillin sodium injection is listed.
CDSCO website (https://cdsco.gov.in) — Reviewed for banned FDC notifications, NSQ alerts, and product recall notices relevant to penicillin-containing formulations.
PvPI (Pharmacovigilance Programme of India) — ADR reporting methodology referenced. IPC National Coordinating Centre, Indian Pharmacopoeia Commission.
Cochrane Database of Systematic Reviews — Reviews on: (a) Secondary prophylaxis for RF (benzathine penicillin vs oral penicillin); (b) Treatment of syphilis in pregnancy; © Antibiotic treatment of tetanus (metronidazole vs penicillin). Referenced for evidence grading.
Indian Heart Journal — Position statements on RF prophylaxis, supply shortage contingency, and 3-weekly vs 4-weekly benzathine penicillin.
Matok I et al. (for syphilis pregnancy safety context) and multiple syphilis treatment cohort studies — Referenced indirectly for syphilis treatment evidence base.

Natural Penicillins

Medication Registry

Benzylpenicillin (Penicillin G)

Phenoxymethylpenicillin (Penicillin V)

Explore More

Quick Links